COMPOSITION COMPRISING CATIONIC AND ANIONIC POLYMERS

A composition of cationic and anionic polymers with fatty acids solubilizes active skin care ingredients, ensuring transparency and environmental friendliness, addressing the need for sustainable cosmetic formulations.

FR3148912A1Active Publication Date: 2024-11-29LOREAL SA
View PDF 61 Cites 0 Cited by

Patent Information

Application Number
FR2023005130
Authority / Receiving Office
FR · FR
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-24
Publication Date
2024-11-29
Estimated Expiration
2043-05-24

AI Technical Summary

Technical Problem

There is a need for a transparent or translucent cosmetic composition that can solubilize active skin care ingredients while incorporating environmentally friendly ingredients, reducing the use of petrochemical compounds and promoting renewable materials.

Method used

A composition comprising cationic and anionic polymers, fatty acids, and active skin care ingredients, formulated to be transparent or translucent, with specific weight ratios and particle sizes to enhance solubility and environmental friendliness.

Benefits of technology

The composition effectively solubilizes active skin care ingredients, maintains transparency, and includes environmentally friendly ingredients, improving skin penetration and reducing environmental impact.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

COMPOSITION COMPRISING CATIONIC AND ANIONIC POLYMERS The present invention relates to a composition comprising: (a) at least one cationic polymer; (b) at least one anionic polymer; and (c) at least one fatty acid. The composition according to the present invention may solubilize at least one active skincare ingredient within the composition, may be transparent or translucent, and may include at least one environmentally friendly ingredient. Figure for abstract: none
Need to check novelty before this filing date? Find Prior Art

Description

Title of the invention: COMPOSITION COMPRISING CATIONIC AND ANIONIC POLYMERS Technical field

[0001] The present invention relates to a composition including anionic and cationic polymers, as well as a cosmetic process using the composition. STATE OF THE ART

[0002] The formulation of environmentally friendly cosmetic products, which are designed and developed with environmental issues in mind, is becoming a major objective in an effort to address global challenges.

[0003] It is therefore essential to propose more sustainable compositions, preparation processes and ingredients to address these environmental concerns.

[0004] In this context, it is important to develop new cosmetic compositions with a better carbon footprint, in particular by promoting the use of renewable raw materials and / or materials with a good naturalness index and / or materials of natural origin and, more particularly, materials of plant origin while reducing the use of compounds of petrochemical origin.

[0005] As widely known, certain cosmetic and / or dermatological compositions and any other compositions are present in an oil-in-water (O / W) form or a water-in-oil (W / O) emulsion form, in particular for the preparation of cosmetic products, such as milks, creams, tonics, serums or eau de toilette. In particular, a fine emulsion such as an O / W nano- or micro-emulsion is particularly interesting in cosmetic products due to its transparent or translucent appearance. DISCLOSURE OF THE INVENTION

[0006] There is a need for a transparent or translucent composition that can solubilize a skin care active ingredient in the composition, while including one or more environmentally friendly ingredients.

[0007] Thus, a first objective of the present invention is to provide a composition which can solubilize a skin care active ingredient in the composition, and can be transparent or translucent.

[0008] Furthermore, a second objective of the present invention is to provide a composition which may include at least one environmentally friendly ingredient.

[0009] The above objectives of the present invention can be achieved by a composition, preferably a cosmetic composition, and more preferably a cosmetic composition for the skin, comprising a. at least one cationic polymer; b. at least one anionic polymer and c. at least one fatty acid.

[0010] The composition according to the present invention may further comprise (d) at least one active skin care ingredient, preferably with a logP of -1 or more, more preferably 1 or more, and even more preferably 2 or more.

[0011] The composition according to the present invention can satisfy the following conditions:

[0012] the total amount of (a) cationic polymer, (b) anionic polymer, (c) acid fat and (d) skin care active ingredient is less than 1.5% by weight, preferably less than 1.0% by weight, and more preferably less than 0.5% by weight, relative to the total weight of the composition;

[0013] the weight ratio of the amount of (a) cationic polymer / total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.7, preferably less than 0.5, and more preferably less than 0.3;

[0014] the weight ratio of the amount of (b) anionic polymer / total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.9, preferably less than 0.8, and more preferably less than 0.7; and

[0015] the weight ratio of the amount of (d) skin care active ingredient to the total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid, and (d) skin care active ingredient is less than 0.16, preferably less than 0.12, and more preferably less than 0.08.

[0016] The (a) cationic polymer can be hydrophobized by the (c) fatty acid.

[0017] The (a) cationic polymer may be selected from the group consisting of cyclo alkyldiallylamine polymers and dialkyldiallylammonium cyclopolymers such as (co)polydiallyldialkyl ammonium chloride, (co)polyamines such as (co)polylysines and chitosans, cationic (co)polyamino acids such as collagen, cationic cellulose polymers and salts thereof.

[0018] The (a) cationic polymer may have a molecular weight of less than 20,000, preferably less than 15,000 and more preferably less than 10,000.

[0019] The amount of the (a) cationic polymer(s) in the composition according to the present invention may be from 0.001% to 15% by weight, preferably from 0.005% to 10% by weight, and more preferably from 0.01% to 5% by weight, relative to the total weight of the composition.

[0020] The (b) anionic polymer may be selected from the group consisting of polysaccharides such as alginic acid, hyaluronic acid and cellulosic polymers, Anionic (co)polyamino acids such as (co)polyglutamic acids, (co)poly(meth)acrylic acids, (co)polyamic acids, (co)polystyrene sulfonate, (co)poly(vinyl sulfates), dextran sulfate, chondroitin sulfate, (co)polymaleic acids, (co)polyfumaric acids, (co)polymers of maleic acid and salts thereof.

[0021] The amount of the (b) anionic polymer(s) in the composition according to the present invention may be from 0.001% to 15% by weight, preferably from 0.005% to 10% by weight, and more preferably from 0.01% to 5% by weight, relative to the total weight of the composition.

[0022] The (c) fatty acid may be chosen from C4-C26, preferably C6-C24, more preferably C8-C22 saturated and unsaturated, linear or branched fatty acids.

[0023] The amount of the (c) fatty acid(s) in the composition according to the present invention may be from 0.001% to 10% by weight, preferably from 0.005% to 5% by weight, and more preferably from 0.01% to 1% by weight, relative to the total weight of the composition.

[0024] The amount of the (d) active skin care ingredient(s) in the composition according to the present invention may be from 0.001% to 10% by weight, preferably from 0.003% to 5% by weight, and more preferably from 0.005% to 1% by weight, relative to the total weight of the composition.

[0025] Preferably, the composition according to the present invention comprises (e) water.

[0026] The amount of (e) water in the composition according to the present invention may be from 50% to 99% by weight, preferably from 55% to 98% by weight and, more preferably from 60% to 97% by weight, relative to the total weight of the composition.

[0027] The composition according to the present invention may comprise at least one particle with a particle size of less than 1000 nm, preferably less than 500 nm, and more preferably less than 300 nm.

[0028] The composition according to the present invention may comprise no surfactant having at least one polyoxyethylene unit or comprises a surfactant having at least one polyoxyethylene unit in an amount of less than 1% by weight, preferably less than 0.1% by weight, and more preferably less than 0.01% by weight, relative to the total weight of the composition.

[0029] In a preferred embodiment, the composition according to the present invention may comprise

[0030] (a) at least one cationic polymer chosen from chitosans;

[0031] (b) at least one anionic polymer chosen from polysaccharides such as car- raghenane;

[0032] (c) at least one fatty acid;

[0033] (d) at least one skin care active ingredient selected from the group consisting of 2-N-oleoylaminooctadecane-l,3-diol, tocopherol, retinol, stearyl glycyrrhetinate, ascorbic acid, ascorbyl tetraisopalmitate, 2-N-stearoylaminooctadecane-l,3,4-triol, capryloyl salicylic acid and a mixture thereof; and

[0034] (e) water,

[0035] in which

[0036] the total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 1.5% by weight, preferably less than 1.0% by weight, and more preferably less than 0.5% by weight, relative to the total weight of the composition;

[0037] the weight ratio between the amount of (a) cationic polymer / total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.7, preferably less than 0.5, and more preferably less than 0.3;

[0038] the weight ratio of the amount of (b) anionic polymer / total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.9, preferably less than 0.8, and more preferably less than 0.7; and

[0039] the weight ratio of the amount of (d) skin care active ingredient to the total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid, and (d) skin care active ingredient is less than 0.16, preferably less than 0.12, and more preferably less than 0.08.

[0040] The present invention also relates to a cosmetic process for a keratinous substance such as skin, comprising

[0041] the application to the keratinous substance of the composition according to the present invention; and

[0042] drying the composition to form a cosmetic film on the keratinous substance. Best mode for carrying out the invention

[0043] After careful research, the inventors have discovered that it is possible to provide a composition which can solubilize a skin care active ingredient in the composition, can be transparent or translucent, and can include at least one environmentally friendly ingredient.

[0044] Thus, the composition according to the present invention comprises:

[0045] (a) at least one cationic polymer;

[0046] (b) at least one anionic polymer and

[0047] (c) at least one fatty acid.

[0048] The composition according to the present invention may solubilize (d) at least one skin care active ingredient in the composition, and may be transparent or translucent.

[0049] The (a) cationic polymer may form a complex with the (c) fatty acid, by the ionic interaction between the amino groups of the (a) cationic polymer with the carboxy groups of the (c) fatty acid. The (a) cationic polymer may be hydrophobized by the (c) fatty acid. The above complex may enhance the solubility, if any, of the (d) skin care active ingredient, especially the lipophilic skin care active ingredient.

[0050] The anionic polymer (b) may also be included in the complex.

[0051] Ingredients (a) to (c) in the composition according to the present invention may form a particle. The particle may be hydrophobized by the (c) fatty acid.

[0052] Thus, the above particle may be formed by the (a) cationic polymer, the (b) anionic polymer and the (c) fatty acid, and may have a hydrophobized interior space in which the (d) skin care active ingredient may be included.

[0053] The size of the above particle is small and may be nanometer level, i.e. less than 1000 nm. Thus, the composition according to the present invention may be transparent or translucent.

[0054] Furthermore, since the particle size is small, the penetration of the (d) skin care active ingredient, if any, in the particle into the skin, particularly into the stratum corneum, can be improved.

[0055] In addition, ingredients (a) to (c) may be derived from renewable materials such as plants and / or biodegradable materials. Thus, by selecting ingredients (a) to (c) from such renewable materials, they may be environmentally friendly. Therefore, the composition according to the present invention may include an environmentally friendly ingredient.

[0056] If the composition according to the present invention does not include any surfactant having at least one polyoxyethylene unit or a small amount of this or these surfactants, the composition according to the present invention can be less irritable. Also, since most of these surfactants are not biodegradable, the composition according to the present invention can be more environmentally friendly.

[0057] Hereinafter, the composition according to the present invention will be explained in more detail. [Composition]

[0058] (Cationic polymer)

[0059] The composition according to the present invention comprises (a) at least one cationic polymer. Only one type of cationic polymer may be used, but two or more different types of cationic polymers may be used in combination.

[0060] A cationic polymer has a positive charge density. The charge density of the (a) cationic polymer may be from 0.01 meq / g to 20 meq / g, preferably from 0.05 to 15 meq / g and, more preferably, from 0.1 to 10 meq / g.

[0061] It may be preferable that the molecular weight of the (a) cationic polymer is 1000 or more, preferably 2000 or more, more preferably 3000 or more, and even more preferably 4000 or more.

[0062] Unless otherwise defined in the descriptions, “molecular weight” means weight average molecular weight.

[0063] The (a) cationic polymer may have at least one positively chargeable and / or positively charged moiety selected from the group consisting of a primary, secondary or tertiary amino group, a quaternary ammonium group, a guanidine group, a biguanide group, an imidazole group, an imino group and a pyridyl group. The term "(main) amino group" herein refers to a -NH2 group.

[0064] The (a) cationic polymer may be a homopolymer or a copolymer. The term "copolymer" is intended to refer to both copolymers obtained from two kinds of monomers and those obtained from more than two kinds of monomers, such as terpolymers obtained from three kinds of monomers.

[0065] The (a) cationic polymer may be chosen from natural and synthetic cationic polymers, and preferably from natural cationic polymers. Non-limiting examples of cationic polymers are as follows.

[0066] (1) Homopolymers and copolymers derived from acrylic or me- esters and amides thacrylics and comprising at least one unit chosen from the units of the following formulas: O 0 W § IX AA TO i ! ---Rs Rf' ''R; | R;' ' Rv Rs R; -------Q------. 0^0 NH X' HAS R$--R'—R§ RS

[0067] in which:

[0068] R1 and R2, which may be the same or different, are chosen from hydrogen and alkyl groups comprising from 1 to 6 carbon atoms, for example, methyl and ethyl groups;

[0069] R3, which may be the same or different, is chosen from hydrogen and CH3;

[0070] the symbols A, which may be identical or different, are chosen from linear or branched alkyl groups comprising from 1 to 6 carbon atoms, for example from 2 to 3 carbon atoms and hydroxyalkyl groups comprising from 1 to 4 carbon atoms;

[0071] R4, R5 and R6, which may be the same or different, are chosen from groups alkyl comprising from 1 to 18 carbon atoms and benzyl groups, and in at least one embodiment, alkyl groups comprising from 1 to 6 carbon atoms; and

[0072] X is an anion derived from an inorganic or organic acid, such as methosulfate anions and halides, for example chloride and bromide.

[0073] The copolymers of family (1) may also comprise at least one unit derived from comonomers which may be chosen from acrylamides, methacrylamides, diacetone acrylamides, acrylamides and methacrylamides substituted on the nitrogen atom by C1-C4 lower alkyl groups, groups derivatives of acrylic or methacrylic acids and esters thereof, vinyl lactams such as vinylpyrrolidone and vinylcaprolactam, and vinyl esters.

[0074] Examples of copolymers of family (1) include, but are not limited to:

[0075] copolymers of acrylamide and dimethylaminoethyl methacrylate quaternized with dimethyl sulfate or with a dimethyl halide,

[0076] copolymers of acrylamide and methacryloyloxyethyltrimethylammonium chloride described, for example, in European patent application No. 0 080 976,

[0077] copolymers of acrylamide and methacryloyloxyethyltrimethylammonium methsulfate, vinylpyrrolidone / dialkylaminoalkyl acrylate or methacrylate copolymers, quaternized or not, described, for example, in French patents Nos. 2 077 143 and 2 393 573,

[0078] dimethylaminoethyl methacrylate / vinylcaprolactam / vinylpyrrolidone terpolymers,

[0079] vinylpyrrolidone / methacrylamidopropyldimethylamine copolymers, quaternized vinylpyrrolidone / dimethylaminopropylmethacrylamide copolymers and

[0080] crosslinked polymers of methacryloyloxy(Ci-C4)alkyltri(Ci-C4)alkylammonium salts such as polymers obtained by homopolymerization of quaternized dimethylaminoethyl methacrylate with methyl chloride, or by copolymerization of acrylamide with quaternized dimethylaminoethyl methacrylate with methyl chloride, the homopolymerization or copolymerization being followed by crosslinking with a compound containing olefinic unsaturation, in particular methylenebisacrylamide.

[0081] (2) Cationic cellulose polymers such as cellulose ether derivatives comprising one or more quaternary ammonium groups described, for example, in French patent No. 1,492,597, such as the polymers sold under the names “JR” (JR 400, JR 125, JR 30M) or “LR” (LR 400, LR 30M) by the company Union Carbide Corporation. These polymers are also defined in the CTFA dictionary as quaternary ammoniums of hydroxyethylcellulose reacted with an epoxide substituted by a trimethylammonium group.

[0082] It is preferable that the cationic cellulose polymer has at least one quaternary ammonium group, preferably a trialkylquaternaryammonium group and more preferably, a trimethylquaternaryammonium group.

[0083] The quaternary ammonium group may be present in a quaternary ammonium group which may be represented by the following chemical formula (I): OH

[0084] in which

[0085] each of R1 and R2 denotes a C1-C3 alkyl group, preferably a methyl or ethyl group, and more preferably a methyl group,

[0086] R3 denotes a C, 24 alkyl group, preferably a methyl or ethyl group, and more preferably a methyl group,

[0087] X- denotes an anion, preferably a halide, and more preferably a chloride,

[0088] n denotes an integer from 0 to 30, preferably from 0 to 10 and more preferably 0, and

[0089] R4 denotes a C1-4 alkylene group, preferably an ethylene or propylene group.

[0090] The leftmost ether bond (-O-) in chemical formula (I) above can attach to the sugar ring of the polysaccharide.

[0091] It is preferable that the group containing the quaternary ammonium group is -O-CH2-CH(OH)-CH2-N+(CH3)3.

[0092] (3) Cationic cellulose polymers such as cellulose copolymers and Cellulose derivatives grafted with a water-soluble quaternary ammonium monomer and described, for example, in U.S. Patent No. 4,131,576, such as hydroxyalkylcelluloses, for example, hydroxymethyl-, hydroxyethyl- and hydroxypropylcelluloses grafted, for example, with a salt selected from methacryloyl-ethyltrimethylammonium, methacrylamidopropyltrimethylammonium and dimethyldiallylammonium salts.

[0093] Commercial products corresponding to these polymers include, for example, the products marketed under the names “Celquat® L 200” and “Celquat® H 100” by the company National Starch.

[0094] (4) Non-cellulosic cationic polysaccharides described in US patents Nos. 3,589,578 and 4,031,307, such as guar gums comprising cationic trialkylammonium groups, cationic hyaluronic acid and dextran hydroxypropyl trimonium chloride. Guar gums modified with a salt, for example the chloride, of 2,3-epoxypropyltrimethylammonium (guar hydroxypropyltrimonium chloride) may also be used.

[0095] These products are sold, for example, under the trade names JAGUAR® C13 S, JAGUAR® C15, JAGUAR® C17 and JAGUAR® C162 by the company MEYHALL.

[0096] (5) Polymers comprising piperazinyl units and alkylene or hy- groups Divalent droxyalkylene polymers comprising straight or branched chains, optionally interrupted with at least one entity selected from oxygen, sulfur, nitrogen, aromatic rings and heterocyclic rings, as well as the oxidation and / or quaternization products of these polymers. These polymers are described, for example, in French patents Nos. 2,162,025 and 2,280,361.

[0097] (6)Water-soluble polyamino amides prepared, for example, by polycondensation of an acidic compound with a polyamine; these polyamino amides being optionally crosslinked with a moiety selected from epihalohydrins; diepoxides; dianhydrides; unsaturated dianhydrides; bisunsaturated derivatives; bishalohydrins; bisazetidiniums; bishaloacyldiamines; bisalkyl halides; oligomers resulting from the reaction of a difunctional compound which is reactive with a moiety selected from bishalohydrins; bisazetidiniums, bishaloacyldiamines, bisalkyl halides; epihalohydrins; diepoxides and bisunsaturated derivatives; the crosslinking agent being used in an amount ranging from 0.025 to 0.35 mole per amine group of the polyamino amide; these polyamino amides being optionally alkylated or, if they comprise at least one tertiary amine function, they can be quaternized.These polymers are described, for example, in French patents Nos. 2,252,840 and 2,368,508.

[0098] (7) Polyamino amide derivatives resulting from the condensation of polyamines of poly- alkylene with polycarboxylic acids, followed by alkylation with difunctional agents, for example, adipic acid / dialkylaminohydroxyalkyldialkylenetriamine polymers in which the alkyl group comprises from 1 to 4 carbon atoms, such as methyl, ethyl and propyl groups, and the alkylene group comprises from 1 to 4 carbon atoms, such as an ethylene group. These polymers are described, for example, in French patent No. 1,583,363. In at least one embodiment, these derivatives may be selected from adipic acid / dimethylaminohydroxypropyldiethylenetriamine polymers.

[0099] (8) Polymers obtained by reaction of a polyalkylene polyamine comprising two primary amine groups and at least one secondary amine group, with a dicarboxylic acid selected from diglycolic acid and saturated aliphatic dicarboxylic acids comprising from 3 to 8 carbon atoms. The molar ratio of polyalkylene polyamine to dicarboxylic acid may range from 0.8:1 to 1.4:1; the resulting polyamino amide being reacted with epichlorohydrin in a molar ratio of epichlorohydrin to the secondary amine group of the polyamino amide ranging from 0.5:1 to 1.8:1. These polymers are described, for example, in U.S. Patent Nos. 3,227,615 and 2,961,347.

[0100] (9) Alkyldiallylamine cyclopolymers and dialkyldiallyl- cyclopolymers ammonium, such as homopolymers and copolymers comprising, as the main constituent of the chain, at least one unit from among the units of formulae (Ia) and (Ib): <Ia) -(CH^t—0Rî2 XÇ(R^) —CHr-- H^CX ...,.^2 XN*'"' y~ / \ \ Rw Ru (Ib) KM — CRu xç(?W ■—GHg— H?OX. ,CHg ' \r<

[0101] in which:

[0102] k and t, which may be identical or different, are equal to 0 or 1, the sum k+t being equal to 1;

[0103] Rn is chosen from hydrogen and methyl groups;

[0104] R10 and Rn, which may be the same or different, are selected from alkyl groups comprising from 1 to 6 carbon atoms, hydroxyalkyl groups in which the alkyl group comprises, for example, from 1 to 5 carbon atoms and lower (C1-C4)alkylamido groups, or R10 and Rn may form, with the nitrogen atom to which they are attached, heterocyclic groups such as piperidinyl and morpholinyl; and

[0105] Y1 is an anion such as bromide, chloride, acetate, borate, citrate, tartrate, bisulfate, bisulfite, sulfate and phosphate. These polymers are described, for example, in French patent No. 2,080,759 and in its certificate of addition 2,190,406.

[0106] In one embodiment, Rio and Rn, which may be the same or different, are selected from alkyl groups comprising from 1 to 4 carbon atoms.

[0107] Among these polymers, mention may be made, but not limited to, (co)polydiallyldialkyl ammonium chloride such as the homopolymer of dimethyldiethylammonium chloride sold under the name "MERQUAT® 100" by the company CALGON (and its counterparts of low average molecular weight by weight) and the copolymers of diallyldimethylammonium chloride and acrylamide sold under the name "MERQUAT® 550".

[0108] Quaternary diammonium polymers comprising at least one repeating unit of formula (II): Rn Rw (ll) .......N"......Ai.....N*.......B:......... IX | X Rw

[0109] in which:

[0110] Rn, Ru, Rb and R16, which may be the same or different, are selected from aliphatic, alicyclic and arylaliphatic groups comprising from 1 to 20 carbon atoms and lower aliphatic hydroxyalkyl groups, or Rn, R[4, R15 and R16, together or separately, with the nitrogen atoms to which they are attached, heterocycles alternatively comprising a second heteroatom other than nitrogen, or R13, R14, R15, and R16 which may be the same or different, are selected from linear or branched C1-C6 alkyl groups substituted by at least one group selected from alkyl groups, ester groups, acyl groups, amide groups, -CO-O-Rp-E groups and -CO-NH-Rp-E groups, where R17 is an alkylene group and E is an ammonium group quaternary;

[0111] Ai and Bb which may be identical or different, are chosen from polymethylene groups comprising from 2 to 20 carbon atoms, which may be linear or branched, saturated or unsaturated, and which may comprise, linked or intercalated in the main chain, at least one entity chosen from aromatic rings, oxygen, sulfur, sulfoxide groups, sulfone groups, disulfide groups, amino groups, alkylamino groups, hydroxyl groups, quaternary ammonium groups, ureido groups, amide groups and ester groups, and

[0112] X denotes an anion derived from an inorganic or organic acid;

[0113] Ai, Rn and Rb can form, in conjugation with the two nitrogen atoms to which they are attached, a piperazine ring;

[0114] if Ai is chosen from linear or branched, saturated or unsaturated alkylene or hydroxyalkylene groups, Bi can be chosen from:

[0115] -(CH2)n-CO-E'-OC-(CH2)n-

[0116] in which E' is chosen from:

[0117] a) glycolic residues of formula -OZO-, in which Z is chosen from linear or branched hydrocarbon-based groups and groups of the following formulas:

[0118] -(CH2-CH2-O)X-CH2-CH2-

[0119] -[CH2-CH(CH3)-O]y-CH2-CH(CH3)-

[0120] in which x and y, which may be the same or different, are chosen from integers ranging from 1 to 4, which represent a defined and unique degree of polymerization, and numbers ranging from 1 to 4, which represent an average degree of polymerization;

[0121] b) a bis-secondary diamine residue such as piperazine derivatives;

[0122] c) bis-primary diamine residues of formula -NH-Y-NH-, wherein Y is selected from linear or branched hydrocarbon-based groups and the divalent group -CH2-CH2-SS-CH2-CH2-. and

[0123] d) ureylene groups of formula -NH-CO-NH-.

[0124] In at least one embodiment, X is an anion such as chloride or bromide.

[0125] Polymers of this type are described, for example, in French patents Nos. 2,320,330; 2,270,846; 2,316,271; 2,336,434; and 2,413,907 and in US patents Nos. 2,273,780; 2,375,853; 2,388,614; 2,454,547; 3,206,462; 2,261,002; 2,271,378; 3,874,870; 4,001,432; 3,929,990; 3,966,904; 4,005,193; 4,025,617; 4,025,627; 4,025,653; 4,026,945 and 4,027,020.

[0126] Non-limiting examples of such polymers include those comprising at least one repeating unit of formula (III): Rts Ris (ni)

[0127] in which

[0128] Rn, Ru, Rb and R[6, which may be the same or different, are chosen from alkyl and hydroxyalkyl groups comprising from 1 to 4 carbon atoms, n and p, which may be the same or different, are integers ranging from 2 to 20, and X is an anion derived from an inorganic or organic acid.

[0129] (1 l) Polyquaternary ammonium polymers comprising units of formula (IV):

[0130] in which:

[0131] Ri8, Rw, R2o and R2i, which may be identical or different, are chosen from hydrogen, methyl, ethyl, propyl, [3-hydroxyethyl, [3-hydroxypropyl, -CH 2CH2(OCH2CH2)pOH, wherein p is selected from integers ranging from 0 to 6, provided that R[8, R19, R20 and R2[ are not simultaneously hydrogen,

[0132] r and s, which may be the same or different, are selected from integers ranging from 1 to 6,

[0133] q is chosen from integers ranging from 0 to 34,

[0134] X is an anion, such as a halide, and

[0135] A is chosen from dihalide radicals and -CH2-CH2-O-CH2-CH2-.

[0136] These compounds are described, for example, in European patent application No. 0 122 324.

[0137] (12)Quaternary polymers of vinylpyrrolidone and vinylimidazole.

[0138] Other examples of suitable cationic polymers include, but are not limited to, cationic proteins and cationic protein hydrolysates, polyalkyleneimines, such as polyethyleneimines, polymers comprising units selected from vinylpyridine and vinylpyridinium units, polyamine and epichlorohydrin condensates, quaternary polyureylenes and chitin derivatives.

[0139] According to one embodiment of the present invention, the (a) cationic polymer is selected from cellulose ether derivatives comprising quaternary ammonium groups, such as the products sold under the name "JR 400" by the company UNION CARBIDE CORPORATION, cationic cyclopolymers, for example, homopolymers and copolymers of dimethyldiallylammonium chloride sold under the names MERQUAT® 100, MERQUAT® 550, and MERQUAT® S by the company CALGON, guar gums modified with a 2,3-epoxypropyltrimethylammonium salt, and quaternary polymers of vinylpyrrolidone and vinylimidazole.

[0140] (13)Polyamines

[0141] As (a) cationic polymer, it is also possible to use (co)polyamines, which may be homopolymers or copolymers, with a plurality of amino groups. The amino group may be a primary, secondary, tertiary or quaternary amino group. The amino group may be present in the polymer backbone or a pendant group, if any, of the (co)polyamines.

[0142] Examples of (co)polyamines include chitosans, (co)polyallylamines, (co)polyvinylamines, (co)polyanilines, (co)polyvinylimidazoles, (co)polydimethylaminoethylene methacrylates, (co)polyvinylpyridines such as (co)poly-1-methyl-2-vinylpyridines, (co)polyimines such as (co)polyethyleneimines, (co)polypyridines such as (co)poly(quaternary pyridines), (co)polybiguanides such as (co)polyaminopropyl biguanides, (co)polylysines, (co)polyornithines, (co)polyarginines, (co)polyhistidines, aminodextrans, aminocelluloses, amino(co)polyvinyl acetals and their salts.

[0143] As (co)polyamines, it may be preferable to use (co)polylysines. Polylysine is well known. Polylysine may be a natural homopolymer of L-lysine that can be produced by bacterial fermentation. For example, polylysine may be e-Poly-L-lysine, typically used as a natural preservative in food products. Polylysine is a polyelectrolyte that is soluble in polar solvents such as water, propylene glycol, and glycerol. Polylysine is commercially available in various forms, such as poly D-lysine and poly L-lysine. Poly-L-Lysine is preferable. Polylysine may be in the form of a salt and / or a solution.

[0144] (14)Cationic polyamino acids

[0145] As (a) cationic polymer, it may be possible to use cationic polyamino acids, which may be cationic homopolymers or copolymers, with a plurality of amino groups and carboxyl groups. The amino group may be a primary, secondary, tertiary or quaternary amino group. The amino group may be present in a polymer backbone or a pendant group, if any, of the cationic polyamino acids. The carboxyl group may be present in a pendant group, if any, of the cationic polyamino acids.

[0146] Examples of cationic polyamino acids include cationized collagen, cationized gelatin, hydroxypropyl stear-dimonium hydrolyzed wheat protein, hydroxypropyl cocodimonium hydrolyzed wheat protein, hydroxypropyl trimonium hydrolyzed conchiolin protein, hydroxypropyl steardimonium hydrolyzed soy protein, hydroxypropyl trimonium hydrolyzed soy protein, hydroxypropyl cocodimonium hydrolyzed soy protein, and the like.

[0147] The following descriptions relate to preferable embodiments of the cationic polymer.

[0148] It is preferable that the (a) cationic polymer is selected from the group consisting of alkyldiallylamine cyclopolymers and dialkyldiallylammonium cyclopolymers such as (co)polydiallyldialkyl ammonium chloride, (co)polyamines such as (co)polylysines, cationic (co)polyamino acids such as collagen, cationic cellulose polymers and salts thereof.

[0149] It is more preferable that the (a) cationic polymer is chosen from chitosans.

[0150] It is preferable that the chitosan has a molecular weight (Da) of less than 20,000, more preferably less than 15,000, and even more preferably less than 10,000. In other words, the (a) cationic polymer may be a low molecular weight chitosan.

[0151] The molecular weight (Da) of chitosan may be greater than 1000, preferably greater than 1500, and more preferably greater than 2000.

[0152] Thus, the molecular weight (Da) of chitosan may be greater than 1000 and less than 20,000, preferably greater than 1500 and less than 15,000, and more preferably greater than 2000 and less than 10,000.

[0153] Unless otherwise defined in the descriptions, "molecular weight" means weight average molecular weight. Molecular weight may be measured or determined by gel permeation chromatography, for example, in accordance with ASTM D5296-19.

[0154] Chitosan is very rare in nature. It is only reported in the exoskeletons of certain insects such as termite queens and in the cell walls of a particular class of fungi, the zygomycetes.

[0155] Chitosan can be obtained by deacetylation of chitin. Chitin is a polysaccharide composed of several N-acetyl-D-glucosamine units linked together by a [3 (1,4)] type bond.

[0156] The ideal chemical structure of chitosan is a sequence of monomers [3-D-glucosamine linked by a glycosidic bond (1—>4).

[0157] The "chitosan" according to the present invention designates any copolymer formed from constituent units N-acetyl-D-glucosamine and D-glucosamine, the degree of acetylation of which is less than 90%, preferably less than 80%, preferably less than 70%, preferably less than 60%, preferably less than 50%. Chitosan consists of glucosamine sugar units (deacetylated units) and N-acetyl-D-glucosamine units (acetylated units) linked together by bonds of type [3 (1,4) and is a polymer of type Poly (N-acetyl-D-glucosamine)-poly (D-glucosamine).

[0158] More preferably, the degree of acetylation of the chitosan is less than or equal to 40%, preferably less than or equal to 35%, preferably less than or equal to 25%, preferably less than or equal to 15%, and preferably less than or equal to 10%.

[0159] The degree of acetylation is the percentage of acetylated units relative to the number of total units, it can be determined by Fourier transform infrared spectroscopy (FTIR) or by titration with a strong base.

[0160] The chitosan of the present invention is preferably a polysaccharide prepared from a fungal origin. In particular, it is extracted and purified from safe and abundant foods or biotechnological fungal sources such as Agaricus bisporus or Aspergillus niger.

[0161] The chitosan of the present invention is preferably derived from the mycelium of an Ascomycete fungus, and in particular Aspergillus niger and / or a Basidiomycete fungus, and in particular Lentinula edodes (shiitake) and / or Agaricus bisporus. Preferably, the fungus is Aspergillus niger.

[0162] Chitosan can be of genetically modified organism (GMO) origin, but preferably of non-GMO origin.

[0163] The chitosan according to the present invention is native, that is to say it is not modified. In particular, it does not contain any chemical modification.

[0164] A process for preparing chitosan is that described in WO03 / 068824.

[0165] Preferably, the chitosan used in the present invention is in powder form. It is marketed by Glentham Life Science under the name GU3511.

[0166] The amount of the (a) cationic polymer(s) in the composition according to the present invention may be 0.001% by weight or more, preferably 0.005% by weight or more, and more preferably 0.01% by weight or more, relative to the total weight of the composition.

[0167] The amount of the (a) cationic polymer(s) in the composition according to the present invention may be 15% by weight or less, preferably 10% by weight or less, and more preferably 5% by weight or less, relative to the total weight of the composition.

[0168] The amount of the (a) cationic polymer(s) in the composition according to the present invention may be from 0.001% to 15% by weight, preferably from 0.005% to 10% by weight, and more preferably from 0.01% to 5% by weight, relative to the total weight of the composition.

[0169] (Anionic polymer)

[0170] The composition according to the present invention comprises (b) at least one anionic polymer. A single type of anionic polymer may be used, or two or more different types of anionic polymers may be used in combination.

[0171] An anionic polymer has a negative charge density. The charge density of the (b) anionic polymer may be from 0.1 meq / g to 20 meq / g, preferably from 1 meq / g to 15 meq / g, and more preferably from 4 meq / g to 10 meq / g if the (b) anionic polymer is a synthetic anionic polymer, and the average degree of substitution of the (b) anionic polymer may be from 0.1 to 3.0, preferably from 0.2 to 2.7, and more preferably from 0.3 to 2.5 if the (b) anionic polymer is a natural anionic polymer.

[0172] In one embodiment, the (d) anionic polymer may have a charge density of 2.04 mmol / g or greater, preferably 3.00 mmol / g or greater, and more preferably 4.00 mmol / g or greater.

[0173] It may be preferable that the molecular weight of the (b) anionic polymer is 1000 or more, preferably 2000 or more, even more preferably 5000 or more, even more preferably 10,000 or more, even more preferably 50,000 or more, even more preferably 100,000, and even more preferably 1,000,000 or more.

[0174] Unless otherwise defined in the descriptions, “molecular weight” may refer to weight average molecular weight.

[0175] The (b) anionic polymer may have at least one negatively chargeable and / or negatively charged moiety selected from the group consisting of a sulfuric group, a sulfate group, a sulfonic group, a sulfonate group, a phosphoric group, a phosphate group, a phosphonic group, a phosphonate group, a carboxylic group and a carboxylate group.

[0176] The (b) anionic polymer may be a homopolymer or a copolymer. The term "copolymer" includes both copolymers obtained from two kinds of monomers and those obtained from more than two kinds of monomers, such as terpolymers obtained from three kinds of monomers.

[0177] The (b) anionic polymer may be chosen from natural and synthetic anionic polymers, and preferably from natural anionic polymers.

[0178] The (b) anionic polymer may comprise at least one hydrophobic chain.

[0179] The (b) anionic polymer, which may comprise at least one hydrophobic chain, can be obtained by copolymerization of a monomer (a) selected from carboxylic acids comprising α,[3-ethylenic unsaturation (monomer a') and a 2-acrylamido-2-methylpropanesulfonic acid (monomer a") with a non-surface-active monomer (b) comprising ethylenic unsaturation other than (a) and / or a monomer (c) comprising ethylenic unsaturation resulting from the reaction of an acrylic monomer comprising α,[3-monoethylenic unsaturation or an isocyanate monomer comprising monoethylenic unsaturation with a non-ionic amphiphilic monohydric component or with a primary or secondary fatty amine.

[0180] Thus, the (b) anionic polymer with at least one hydrophobic chain can be obtained by two synthetic routes: • either by copolymerization of the monomers (a1) and (c), or (a1), (b) and (c), or (a") and (c), or (a"), (b) and (c), • either by modification (and in particular by esterification or amidation) of a copolymer formed from the monomers (a1) or the monomers (a1) and (b), or (a") and (b), by an amphiphilic non-ionic monohydric compound or a primary or secondary fatty amine.

[0181] Mention may in particular be made, as copolymers of 2-acrylamido-2-methylpropanesulfonic acid, of those disclosed in the article “Micelle formation of random copolymers of sodium 2-(acrylamido)-2-methylpropanesulfonate and nonionic surfactant macromonomer in water as studied by fluorescence and dynamic light scattering - Macromolecules, 2000, Vol. 33, No. 10 - 3694-3704” and in applications EP-A-0 750 899 and EP-A-1 069 172.

[0182] The carboxylic acid comprising an α,[3-monoethylenic unsaturation constituting the monomer (a1) can be chosen from numerous acids and, in particular, acrylic acid, methacrylic acid, crotonic acid, itaconic acid and maleic acid. It is preferably acrylic or methacrylic acid.

[0183] The copolymer may comprise a (b) monomer comprising monoethylenic unsaturation which has no surfactant property. Preferred monomers are those which give water-insoluble polymers when homopolymerized. They may be chosen, for example, from C1-C4 alkyl acrylates and methacrylates, such as methyl acrylate, ethyl acrylate, butyl acrylate or the corresponding methacrylates. The most preferred monomers are methyl acrylate and ethyl acrylate. Other monomers which may be used are, for example, styrene, vinyltoluene, vinyl acetate, acrylonitrile and vinylidene chloride. Non-reactive monomers are preferred, these monomers being those in which the single ethylenic group is the only reactive group under the polymerization conditions.However, monomers that include groups that react under heat, such as hydroxyethyl acrylate, may be used optionally.

[0184] Monomer (c) is obtained by reacting an acrylic monomer comprising α,[3-monoethylenic unsaturation, such as (a), or an isocyanate monomer comprising monoethylenic unsaturation with an amphiphilic nonionic monohydric compound or a primary or secondary fatty amine.

[0185] Amphiphilic nonionic monohydric compounds or primary or secondary fatty amines used to produce the nonionic monomer (c) are well known. Amphiphilic nonionic monohydric compounds are generally alkoxylated hydrophobic compounds comprising an alkylene oxide forming the hydrophilic portion of the molecule. Hydrophobic compounds are generally composed of an aliphatic alcohol or an alkylphenol, in which a carbon chain comprising at least six carbon atoms constitutes the hydrophobic portion of the amphiphilic compound.

[0186] The preferred amphiphilic non-ionic monohydric compounds are compounds corresponding to the following formula (V):

[0187] R-(OCH2CHR')m-(OCH2CH2)n-OH (V)

[0188] wherein R is selected from alkyl or alkylene groups comprising from 6 to 30 carbon atoms and alkylaryl groups having alkyl radicals comprising from 8 to 30 carbon atoms, R' is selected from alkyl groups comprising from 1 to 4 carbon atoms, n is an average number ranging from approximately 1 to 150 and m is an average number ranging from approximately 0 to 50, provided that n is at least as large as m.

[0189] Preferably, in the compounds of formula (V), the group R is chosen from alkyl groups comprising from 12 to 26 carbon atoms and al-kylphenyl groups in which the alkyl group is C8-Ci3; the group R' is the methyl group; m = 0 and n = 11 25.

[0190] Preferred primary and secondary fatty amines are composed of one or two alkyl chains comprising from 6 to 30 carbon atoms.

[0191] The monomer used to form the non-ionic urethane monomer (c) may be chosen from a wide variety of compounds. Any compound comprising a copolymerizable unsaturation, such as an acrylic, methacrylic or allyl unsaturation, may be used. The monomer (c) may be obtained in particular from an isocyanate comprising a monoethylenic unsaturation such as, in particular, α,α-dimethyl-m-isopropenylbenzyl isocyanate.

[0192] The monomer (c) may be chosen, in particular, from acrylates, methacrylates or itaconates of oxyethylenated fatty alcohol (1 to 50 EO) C6-C3o, such as steareth-20 methacrylate, oxyethylenated behenyl methacrylate (25 EO), oxyethylenated monocetyl itaconate (20 EO), oxyethylenated monostearyl itaconate (20 EO) or acrylate modified with polyoxyethylenated alcohols (25 EO) C12-C24 and from isocyanates of dimethyl-m-isopropenylbenzyl of oxyethylenated fatty alcohol (1 to 50 EO) C6 -C30, such as, in particular, dimethyl-m-isopropenylbenzyl isocyanate of oxyethylenated behenyl alcohol.

[0193] According to a specific embodiment of the present invention, the (b) anionic polymer is selected from acrylic terpolymers obtained from (a) a carboxylic acid comprising α,[3-ethylenic unsaturation, (b) a non-surface active monomer comprising ethylenic unsaturation other than (a), and (c) a non-ionic urethane monomer which is the reaction product of an amphiphilic non-ionic monohydric compound with an isocyanate comprising monoethylenic unsaturation.

[0194] Mention may in particular be made, as anionic polymers comprising at least one hydrophobic chain, of the acrylic acid / ethyl acrylate / alkyl acrylate terpolymer, such as the product in the form of a 30% aqueous dispersion sold under the name Acusol 823 by Rohm & Haas; the acrylates / steareth-20 methacrylate copolymer, such as the product sold under the name Aculyn 22 by Rohm & Haas; the (meth)acrylic acid / ethyl acrylate / oxyethylenated behenyl methacrylate terpolymer (25 EO), such as the product in the form of an aqueous emulsion sold under the name Aculyn-28 by Rohm & Haas; the acrylic acid / oxyethylenated monocetyl itaconate copolymer (20 EO), such as the product in the form of a 30% aqueous dispersion sold under the name Structure 3001 by National Starch; acrylic acid / oxyethylenated monostearyl itaconate copolymer (20°EO), such as the product under 30% aqueous dispersion form sold under the name Structure 2001 by National Starch; acrylates / acrylate modified with polyoxyethylene (25 EO) Ci2-C24 alcohol copolymer, such as the 30-32% copolymer latex sold under the name Synthalen W2000 by 3V SA; or methacrylic acid / methyl acrylate / ethoxylated behenyl alcohol dimethyl-meta-isopropenylbenzyl isocyanate terpolymer, such as the product in 24% aqueous dispersion form and comprising 40 ethylene oxide groups disclosed in EP-A-0 173 109.

[0195] The (b) anionic polymers may also be Polyester-5, such as the product sold under the name Eastman AQ™ 55S Polymer by EASTMAN CHEMICAL having a chemical formula below. HO-GAGAGAGAGAGAGAGAG-OH SOrNa+ . SO3-Na+

[0196] A: dicarboxylic acid fraction

[0197] G: glycol fraction

[0198] SO3 Na+: sodium sulfo group

[0199] OH: hydroxyl group

[0200] It may be preferable that the (b) anionic polymer is selected from the group consisting of polysaccharides such as alginic acid, hyaluronic acid and cellulose polymers (e.g., carboxymethylcellulose and carrageenan), anionic (co)polyamino acids such as (co)polyglutamic acids, (co)poly(meth)acrylic acids, (co)polyamic acids, (co)polystyrene sulfonate, (co)poly(vinyl sulfate), dextran sulfate, chondroitin sulfate, (co)polymaleic acids, (co)polyfumaric acids, (co)polymers of maleic acid and salts thereof.

[0201] The maleic acid copolymer may comprise one or more maleic acid comonomers, and one or more comonomers selected from vinyl acetate, vinyl alcohol, vinylpyrrolidone, olefins comprising from 2 to 20 carbon atoms and styrene.

[0202] Thus, "maleic acid copolymer" means any polymer obtained by copolymerization of one or more maleic acid comonomers and one or more comonomers chosen from vinyl acetate, vinyl alcohol, vinylpyrrolidone, olefins comprising from 2 to 20 carbon atoms, such as octadecene, ethylene, isobutylene, diisobutylene or isooctylene, and styrene, the maleic acid comonomers being optionally partially or completely hydrolyzed. Hydrophilic polymers will preferably be used, namely polymers having a solubility in water greater than or equal to 2 g / L.

[0203] In an advantageous aspect of the present invention, the maleic acid copolymer may have a mole fraction of maleic acid units between 0.1 and 1, more preferably between 0.4 and 0.9.

[0204] The weight average molar mass of the maleic acid copolymer may be between 1000 and 500,000 and, preferably between 1000 and 50,000.

[0205] It is preferable that the maleic acid copolymer is a styrene / maleic acid copolymer, and more preferably a styrene / maleic acid copolymer.

[0206] A copolymer of styrene and maleic acid in a 50 / 50 ratio will preferably be used.

[0207] For example, styrene / maleic acid copolymer (50 / 50) in the form of 30% ammonium salt in water, sold under the reference SMA1000H® by Cray Valley or styrene / maleic acid copolymer (50 / 50) in the form of 40% sodium salt in water, sold under the reference SMAlOOOHNa® by Cray Valley may be used.

[0208] The use of styrene / maleic acid copolymer such as sodium styrene / maleic acid copolymer can improve the wettability of a film prepared by the composition according to the present invention.

[0209] In a preferred embodiment, the (b) anionic polymer may be selected from hyaluronic acid, its salts (e.g., sodium hyaluronate) and its derivatives.

[0210] Hyaluronic acid can be represented by the following chemical formula.

[0212] In the context of the present invention, the expression "hyaluronic acid" covers in particular the basic unit of hyaluronic acid of formula:

[0213] This is the smallest fraction of hyaluronic acid comprising a dimer of di-saccharide, namely D-glucuronic acid and N-acetylglucosamine.

[0214] The expression "hyaluronic acid and its derivatives" also includes, in the context of the present invention, the linear polymer comprising the polymeric unit described above, linked together in the chain by alternating [3(1,4) and [3(1,3)] glycosidic bonds, having a molecular weight (MW) which can vary between 380 and 13,000,000 daltons. This molecular weight depends largely on the source from which the hyaluronic acid is obtained and / or the preparation methods.

[0215] The expression "hyaluronic acid and its derivatives" also includes, in the context of the present invention, hyaluronic acid salts. As salts, mention may be made of alkali metal salts such as sodium and potassium salts, alkaline earth metal salts such as magnesium salts, ammonium salts and mixtures thereof.

[0216] In its natural state, hyaluronic acid is present in pericellular gels, in the basic substance of connective tissues of vertebrate organs such as the dermis and epithelial tissues and, in particular, in the epidermis, in the synovial fluid of joints, in the vitreous humor, in the human umbilical cord and in the crista galli apophysis.

[0217] Thus, the expression “hyaluronic acid and its derivatives” includes all the fractions or sub-units of hyaluronic acid having a molecular weight in particular in the molecular weight range recalled above.

[0218] In the context of the present invention, hyaluronic acid fractions which do not have inflammatory activity are preferably used.

[0219] As an illustration of the various hyaluronic acid fractions, reference may be made to the document “Hyaluronan fragments: an information-rich System”, R. Stem et al., European Journal of Cell Biology 58 (2006) 699-715, which reviews the listed biological activities of hyaluronic acid as a function of its molecular weight.

[0220] According to a preferred embodiment of the present invention, the hyaluronic acid fractions suitable for the use covered by the present invention have a molecular weight between 50,000 and 5,000,000, in particular between 100,000 and 5,000,000, especially between 400,000 and 5,000,000 Da. In this case, the expression used is high molecular weight hyaluronic acid.

[0221] Alternatively, hyaluronic acid fractions which may also be suitable for the use covered by the present invention have a molecular weight between 50,000 and 400,000 Da. In this case, the expression used is intermediate molecular weight hyaluronic acid.

[0222] As a further alternative, the hyaluronic acid fractions which may be suitable for the use covered by the present invention have a molecular weight of less than 50,000 Da. In this case, the expression used is low molecular weight hyaluronic acid.

[0223] Finally, the expression "hyaluronic acid and its derivatives" also includes hyaluronic acid esters, in particular, those in which all or part of the carboxylic groups of the acid functions are esterified with oxyethylene alkyls or alcohols, containing from 1 to 20 carbon atoms, in particular with a degree of substitution at the level of the D-glucuronic acid of the hyaluronic acid ranging from 0.5 to 50%.

[0224] Mention may in particular be made of methyl, ethyl, n-propyl, n-pentyl, benzyl and dodecyl esters of hyaluronic acid. These esters have in particular been described in D. Campoccia et al. “Semisynthetic resorbable materials from hyaluronan esterification”, Biomaterials 19 (1998) 2101-2127.

[0225] The hyaluronic acid derivative may be, for example, acetylated hyaluronic acid or a salt thereof.

[0226] The molecular weights indicated above are also valid for hyaluronic acid esters.

[0227] The hyaluronic acid may in particular be hyaluronic acid supplied by the company Hyactive under the trade name CPN (PM: 10 to 150 kDa), by the company Soliance under the trade name Cristalhyal (PM: 1.1 times 106), by the company Bioland under the name Nutra HA (PM: 820,000 Da), by the company Bioland under the name Nutra AF (PM: 69,000 Da), by the company Bioland under the name Oligo HA (PM: 6100 Da) or by the company Vam Farmacos Metica under the name D Factor (PM: 380 Da).

[0228] In a preferable embodiment, the (b) anionic polymer may be selected from the group consisting of carrageenan such as i-carrageenan and A-carrageenan, algin, chondroitin sulfate, pectin and a mixture thereof.

[0229] It may be more preferable that the (b) anionic polymer is selected from the group consisting of carrageenan, pectin and a mixture thereof.

[0230] It may be even more preferable that the anionic polymer (b) is chosen from carrageenans.

[0231] The amount of the (b) anionic polymer(s) in the composition according to the present invention may be 0.001% by weight or more, preferably 0.005% by weight or more, and more preferably 0.01% by weight or more, relative to the total weight of the composition.

[0232] The amount of the (b) anionic polymer(s) in the composition according to the present invention may be 15% by weight or less, preferably 10% by weight or less, and more preferably 5% by weight or less, relative to the total weight of the composition.

[0233] The amount of the (b) anionic polymer(s) in the composition according to the present invention may be from 0.001% to 15% by weight, preferably from 0.005% to 10% by weight, and more preferably from 0.01% to 5% by weight, relative to the weight total composition. [Fatty acid]

[0234] The composition according to the present invention comprises (c) at least one fatty acid. If two or more fatty acids are used, they may be the same or different.

[0235] The term "fatty acid" herein refers to a carboxylic acid with a long aliphatic carbon chain.

[0236] The (c) fatty acid has at least 4 carbon atoms, preferably at least 6 carbon atoms and, more preferably, at least 8 carbon atoms. The (c) fatty acid may comprise up to 26 carbon atoms, preferably up to 24 carbon atoms and, more preferably, up to 22 carbon atoms. It is preferable that the (c) fatty acid is chosen from the C4-C26 fatty acid, more preferably the C6-C24 fatty acid, and even more preferably the C8-C22 fatty acid*

[0237] The (c) fatty acid may be chosen from saturated or unsaturated, linear or branched fatty acids. Thus, the (c) fatty acid may be chosen from C4-C26, preferably C6-C24, more preferably C8-C22 saturated and unsaturated, linear or branched fatty acids.

[0238] As unsaturated, linear or branched fatty acids, monounsaturated, linear or branched fatty acids or polyunsaturated, linear or branched fatty acids can be used. As the unsaturated fraction of the unsaturated, linear or branched fatty acids, a carbon-carbon double bond or a carbon-carbon triple bond can be cited.

[0239] As saturated fatty acid, mention may be made, for example, of caprylic acid (C8), pelargonic acid (C9), capric acid (Cio), lauric acid (Ci2), myristic acid (Ci4), pentadecanoic acid (Ci5), palmitic acid (Ci6), heptadecanoic acid (Ci7), stearic acid (Ci8), isostearic acid (Ci8), nonadecanoic acid (Ci9), arachidic acid (C20), behenic acid (C22) and lignoceric acid (C24).

[0240] As unsaturated fatty acid, mention may be made, for example, of myristoleic acid (Ci4), palmitoleic acid (Ci6), oleic acid (Ci8), linoleic acid (Ci8), linolenic acid (Ci8), elaidic acid (Ci8), arachidonic acid (C20), eicosenoic acid (C20), erucic acid (C22) and nervonic acid (C24).

[0241] It is preferable that the (c) fatty acid is chosen from saturated or unsaturated, linear or branched C8-Ci8 fatty acids, and more preferably from the group consisting of caprylic acid, capric acid, oleic acid, linoleic acid, stearic acid, isostearic acid and mixtures thereof.

[0242] The (c) fatty acid may take the form of a free acid or the form of a salt thereof. As the salt of the fatty acid, there may be mentioned an inorganic salt such as an alkali metal salt (a sodium salt, a potassium salt or the like) and an alkali metal salt. earthy (a magnesium salt, a calcium salt, or the like); and an organic salt such as an ammonium salt (a quaternary ammonium salt or the like) and an amine salt (a triethanolamine salt, a triethylamine salt, or the like). A single type of fatty acid salt or a combination of different types of fatty acid salts may be used. In addition, a combination of one or more fatty acids in free acid form and one or more fatty acids in salt form may be used, in which one or more types of salts may also be used.

[0243] The amount of the (c) fatty acid(s) in the composition according to the present invention may be 0.001% by weight or more, preferably 0.005% by weight or more, and more preferably 0.01% by weight or more, relative to the total weight of the composition.

[0244] Furthermore, the amount of the (c) fatty acid(s) in the composition according to the present invention may be 10% by weight or less, preferably 5% by weight or less, and more preferably 1% by weight or less, relative to the total weight of the composition.

[0245] Consequently, the amount of the (c) fatty acid(s) in the composition according to the present invention may range from 0.001% to 10% by weight, preferably from 0.005% to 5% by weight, and more preferably from 0.01% to 1% by weight, relative to the total weight of the composition.

[0246] (Active skin care ingredient)

[0247] The composition according to the present invention may comprise (d) at least one skin care active ingredient. Only one type of (c) skin care active ingredient may be used, but two or more different types of (c) skin care active ingredients may be used in combination.

[0248] It is preferred that the (d) skin care active ingredient has a logP value of -1 or greater, more preferably 1 or greater, and even more preferably 2 or greater.

[0249] Thus, the (d) skin care active ingredient may be hydrophilic or lipophilic, and preferably lipophilic. Lipophilic skin care active ingredient means that the partition coefficient of the lipophilic skin care active ingredient between n-butanol and water is > 1, more preferably > 10 and even more preferably > 100.

[0250] A log P value is a value of the base ten logarithm of the apparent octan-l-ol / water partition coefficient. Log p values ​​are known and are determined by a standard test that determines the concentration of the (d) skin care active ingredient in octan-l-ol and water. The log P can be calculated (clogP) according to the method described in the article by Meylan and Howard: Atom / Fragment contribution method for estimating octanol-water partition coefficients, J. Pharm. Sci., 84: 83-92, 1995. This This value can also be calculated using many commercially available software packages that determine log P based on the structure of a molecule. An example is the U.S. Environmental Protection Agency's Epiwin software.

[0251] Values ​​can be calculated using the ACD (Advanced Chemistry Development) Solaris V4.67 software; they can also be obtained from Exploring QSAR: hydrophobicity, electronic and steric constants (ACS professional reference book, 1995). There is also a website that provides estimated values ​​(address: http: / / esc.syrres.com / interkow / kowdemo.htm).

[0252] The (d) skin care active ingredient may take the form of a salt. Salts of the (d) skin care active ingredient include conventional non-toxic salts of said compounds, such as those formed from an acid or a base.

[0253] It is preferable that the (d) skin care active ingredient is a cosmetic skin care active ingredient and more preferably, a skin emollient or moisturizer, or an anti-aging skin ingredient such as an antioxidant or anti-wrinkle ingredient.

[0254] As (d) skin care active ingredient, ceramide compounds may be mentioned.

[0255] According to the present invention, the expression "ceramide compound" means natural or synthetic ceramides and / or glycoceramides and / or pseudoceramides and / or neoceramides.

[0256] Ceramide compounds are disclosed, for example, in patent applications DE 4424530, DE 4424533, DE 4402929, DE 4420736, WO 95 / 23807, WO 94 / 07844, EP-A-0 646 572, WO 95 / 16665, FR-2 673 179, EP-A-0 227 994, WO 94 / 07844, WO 94 / 24097 and WO 94 / 10131.

[0257] The ceramide compounds which can be used according to the present invention include, and in fact preferentially correspond to, the general formula (I): n ® O C..- TS C / RT r4 r5

[0258] in which

[0259] Ri denotes: • either a saturated or unsaturated and linear or branched hydrocarbon radical in C1-C50, preferably in C5-C50, this hydrocarbon radical being able to be substituted by one or more hydroxyl groups optionally esterified by an acid R7COOH, R7 being a hydrocarbon radical optionally mono- or polyhydroxylated, saturated or unsaturated and linear or branched C1-C35, it is possible that the hydroxyl or hydroxyls of the radical R7 are esterified by a fatty acid C1_c35 optionally mono- or polyhydroxylated, saturated or unsaturated and linear or branched; • or a radical R"-(NR-CO)-R', in which R denotes a hydrogen atom or a mono- or polyhydroxylated hydrocarbon radical, preferably monohydroxylated, in C1-C20, R' and R" are hydrocarbon radicals, the sum of the carbon atoms of which is between 9 and 30, R' being a divalent radical; • or a radical R8-O-CO-(CH2)P, in which R8 denotes a CrC2o hydrocarbon radical and p is an integer ranging from 1 to 12;

[0260] R2 is chosen from a hydrogen atom, a saccharide-type radical, in particular a (glycosyl)n, (galactosyl)m radical or a sulphogalactosyl radical, a sulfate or phosphate residue, a phosphorylethylamine radical and a phosphorylethylammonium radical, in which n is an integer ranging from 1 to 4 and m is an integer ranging from 1 to 8;

[0261] R3 denotes a hydrogen atom or a hydroxylated or non-hydroxylated and saturated or unsaturated C1-C33 hydrocarbon radical, it is possible to esterify the hydroxyl or hydroxyls with an inorganic acid or an acid R7COOH, R7 having the same meaning as above, and it is possible to etherify the hydroxyl or hydroxyls with a (glycosyl)n, (galactosyl)m, sulphogactosyl, phosphorylethylamine or phosphorylethylammonium radical, in which n is an integer ranging from 1 to 4 and m is an integer ranging from 1 to 8, it is also possible to substitute R3 with one or more CrCi4 alkyl radicals;

[0262] R4 denotes a hydrogen atom, a methyl or ethyl radical, a C3-C5o hydrocarbon radical optionally hydroxylated, saturated or unsaturated and linear or branched or a hydrocarbon radical -CH2-CHOH-CH2-O-R6, in which R6 denotes a C10-C26 hydrocarbon radical, or a radical R8-O-CO-(CH2)P, in which R8 denotes a C1C2o hydrocarbon radical and p is an integer ranging from 1 to 12;

[0263] R 5 denotes a hydrogen atom or a C rC30 hydrocarbon radical optionally mono- or polyhydroxylated, saturated or unsaturated and linear or branched, it is possible to etherify the hydroxyl or hydroxyls with a (glycosyl)n, (galactosyl)m, sulphogalactosyl, phosphorylethylamine or phosphorylethylammonium hydrocarbon radical, in which n is an integer ranging from 1 to 4 and m is an integer ranging from 1 to 8; provided that, when R3 and R5 denote hydrogen or when R3 denotes hydrogen and R5 denotes methyl, then R4 does not denote a hydrogen atom or a methyl or ethyl radical.

[0264] Preference is given, among the compounds of formula (I), to ceramides and / or to glycoceramides according to the structure described by Downing in Journal of Lipid Research, Vol. 35, 2060-2068, 1994, or those disclosed in French patent application FR-2 673 179.

[0265] It is preferable that, in formula (I) above, R3 denotes a C15-C26 α-hydroxyalkyl radical, the hydroxyl group being optionally esterified by a C16-C30 α-hydroxyacid.

[0266] The ceramide compounds which are more particularly preferred according to the present invention are the compounds of formula (I) for which R 1 denotes an optionally hydroxylated and saturated or unsaturated alkyl derived from C 14 -C 22 fatty acids; R 2 denotes a hydrogen atom; and R 3 denotes a C 1 -C 17 radical and preferably a C 13 -C 15 radical which is optionally hydroxylated and linear. R 3 preferentially denotes an α-hydroxycetyl radical and R 2, R 4 and R 5 denote a hydrogen atom.

[0267] It is preferable that the ceramide compound is selected from the group consisting of 2-N-linoleoylaminooctadecane-1,3-diol, 2-N-oleoylaminooctadecane-1,3-diol, 2-N-palmitoylaminooctadecane-1,3-diol, 2-N-stearoylaminooctadecane-1,3-diol, 2-N-behenoylaminooctadecane-1,3-diol, 2-N-[2-hydroxypalmitoyl]aminooctadecane-1,3-diol, 2-N-stearoylaminooctadecane-1,3,4-triol, 2-N-palmitoylaminodecane-1,3-diol, and mixtures thereof.

[0268] It is also preferable that the (b) ceramide compound is selected from bis(N-hydroxyethyl-N-cetyl)malonamide, cetyl acid N-(2-hydroxyethyl)-N-(3-cetyloxy-2-hydroxypropyl)amide and N-docosanoyl-N-methyl-D-glucamine.

[0269] Mixtures of ceramide compounds may also be used, such as, for example, mixtures of ceramide(s) 2 and ceramide(s) 5 according to the Downing classification.

[0270] It is also possible to use in particular the compounds of formula (I) for which R denotes a saturated or unsaturated alkyl radical derived from C12-C22 fatty acids; R2 denotes a galactosyl or sulphogalactosyl radical and R3 denotes a saturated or unsaturated C12-C22 hydrocarbon radical and preferably a -CH=CH-(CH 2)12-CH3 group.

[0271] An example of this is the product composed of a mixture of glycoceramides sold under the trade name Glycocer by Waitaki International Biosciences.

[0272] Compounds of formula (I) disclosed in patent applications EP-A-0 227 994, EP-A-0 647 617, EP-A-0 736 522 and WO 94 / 07844 can also be used.

[0273] Such compounds include, for example, Questamide H (bis(N-hydroxyethyl-N-cetyl)malonamide), sold by Quest, or cetyl acid N-(2-hydroxyethyl)-N-(3-cetyloxy-2-hydroxypropyl)amide.

[0274] N-docosanoyl-N-methyl-D-glucamine, disclosed in patent application WO 94 / 24097, can also be used.

[0275] It is of course possible to use mixtures of the various ceramide compounds in the compositions of the present invention.

[0276] As (d) active skin care ingredient, retinoid may be mentioned.

[0277] The retinoid can be retinol (vitamin A), retinal (vitamin A aldehyde), retinoic acid (vitamin A acid), or an ester of retinol and a C2-20 acid such as retinyl propionate, acetate, linoleate, or palmitate (retinyl palmitate).

[0278] Among the retinoids, mention may be made of retinol, retinal, retinoic acid, in particular all-trans retinoic acid and 13-cis retinoic acid, retinol derivatives, such as retinyl acetate, propionate or palmitate, and the retinoids described in the following patent applications: FR 2 370 377, EP 0 199 636. EP 0 325 540 and EP 0 402 072:

[0279] According to a preferred embodiment of the present invention, the retinoid is retinol or proretinol.

[0280] The term "retinol" is intended to refer to all isomers of retinol, i.e., all trans retinol, 13-cis retinol, 11-cis retinol, 9-cis retinol, and 3,4-didehydro retinol.

[0281] As a representative of pro-retinol, retinyl palmitate may be mentioned.

[0282] It is preferable that the retinoid is retinol.

[0283] As (d) active skin care ingredient, lipophilic antioxidant agents may be mentioned.

[0284] According to the present invention, antioxidant agents are compounds or substances which can trap the various forms of radicals which may be present in the skin; preferably, they simultaneously trap all the various forms of radicals present.

[0285] Lipophilic antioxidant agent means that the partition coefficient of the antioxidant agent between n-butanol and water is > 1, more preferably > 10 and even more preferably > 100.

[0286] The lipophilic antioxidant agent is hydrophobic, and is not a hydrophilic antioxidant agent such as ascorbic acid or glutathione.

[0287] As a lipophilic antioxidant agent, mention may be made of phenolic antioxidants which have a hindered phenol structure or a semi-hindered phenol structure within the molecule. Specific examples of such compounds include 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid) which has the INCI name pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, 2,6-di-tert-butyl-4-methylphenol, 2,6-di-tert-butyl-4-ethylphenol, mono- or di- or tri-(a-methylbenzyl)phenol, 2,2'-methylenebis(4-ethyl-6-tert-butylphenol), 2,2'-methylenebis(4-methyl-6-tert-butylphenol), 4,4'-butylidenebis(3-methyl-6-tert-butylphenol), 4,4'-thiobis(3-methyl-6-tert-butylphenol), 2,5-di-tert-butylhydroquinone, 2,5-di-tert-amylhydroquinone, tris[N-(3,5-di-tert-butyl-4-hydroxybenzyl)]isocyanurate, 1,1,3-tris(2-methyl-4-hydroxy-5-tert-butylphenyl)butane, butylidene-l,lbis[3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate], octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate, tetrakis[methylene-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionato]methane, triethylene glycol bis[3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate], 3,9-bis{2-[3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy]-l,l-dimethylethyl}-2,4,8,10-tetraoxaspiro[5.5]undecane, l,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene, 2,2-thiodiethylenebis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate], N,N'-hexamethylenebis(3,5-di-tert-butyl-4-hydroxyhydrocinnamide), 1,6-hexanediol bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate], l,3,5-tris[(4-tert-butyl-3-hydroxy-2,6-xylyl)methyl]-l,3,5-triazine-2,4,6-trione, 2,4-bis(n-octylthio)-6-(4-hydroxy-3,5-di-tert-butylanilino)-l,3,5-triazine, acrylate 2-tert-butyl-6-(3'-tert-butyl-5'-methyl-2'-hydroxybenzyl)-4-methylphenyl, 2-[1-(2-hydroxy-3,5-di-tert-pentylphenyl)ethyl]-4,6-di-tert-pentylphenyl acrylate, 4,6-bis[(octylthio)methyl]-o-cresol, 2,4-di-tert-butylphenyl 3,5-di-tert-butyl-4-hydroxybenzoate and 1,6-hexanediolbis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate].

[0288] As lipophilic antioxidant agents, mention may be made of BHA (butylated hydroxyl anisole) and BHT (butylated hydroxyl toluene), vitamin E (or tocopherols and tocotrienol) and their derivatives, such as the phosphate derivative, for example TPNA® sold by the company Showa Denko, coenzyme Q10 (or ubiquinone), idebenone, certain carotenoids such as lutein, astaxanthin, beta-carotene, polyphenols, phenolic acids and derivatives (for example, chlorogenic acid) and flavonoids, which represent the main subgroup of polyphenols.

[0289] Among the flavonoids, mention may be made in particular of chalcones, hydroxylated chalcones and their reduced derivatives (as described in particular in patent FR 2 608 150), for example phloretin, neohesperidin, phloridzin, aspalathin, etc., flavanones, for example hesperetin and naringin, flavonols, for example quercetin, rutin, flavanols, for example catechin, EGCG, flavones, for example apigenidin, and finally anthocyanins. Mention may also be made of tannins. Reference may also be made to the compounds described in patent applications FR 2 699 818, FR 2 706 478, FR 2 907 339, FR 2 814 943 and FR 2 873 026.

[0290] Polyphenol compounds may in particular be derived from plant extracts selected from extracts of green tea, apple, hops, guava, cocoa or wood such as chestnut, oak, horse chestnut or hazelnut. It is also possible to use a maritime pine bark extract, for example, obtained according to the processes described in US Patent No. 4,698,360, US Patent No. 6,372,266, and US Patent No. 5,720,956. As examples of such extracts, the compound referenced by the INCI name pinus pinaster (bark extract) and by the CTFA name of pine bark extract (pinus pinaster) may be cited. This may include, in particular, the maritime pine bark extract marketed under the name PYCNOGENOL® by the firm BIOLANDES AROMES and / or HORPHAG Research. Other examples include LAYN Natural Ingredients' (maritime) pine bark extract, Blue California's Pine Bark extract and DRT's Oligopin® (Resin and Terpene Derivatives).

[0291] In the context of the present invention, the expression “polyphenol compound” therefore also covers the plant extract itself, rich in these polyphenol compounds.

[0292] Lipophilic antioxidant agents which may also be cited include dithiolanes, for example asparagusic acid, or their derivatives, for example siliceous dithiolane derivatives, in particular those described in patent application FR 2 908 769.

[0293] Lipophilic antioxidant agents that may also be cited include:

[0294] glutathione and its derivatives (GSH and / or GSHOEt), such as alkyl esters of glutathione (such as those described in patent applications FR 2 704 754 and FR 2 908 769); and

[0295] cysteine ​​and its derivatives, such as N-acetylcysteine ​​or L-2-oxothiazolidine-4-carboxylic acid. Reference may also be made to the cysteine ​​derivatives described in patent applications FR 2 877 004 and FR 2 854 160; and

[0296] ferulic acid and its derivatives (esters, salts, etc.). In particular, mention may be made of esters of ferulic acid and C1-C30 alcohols, in particular methyl ferulate, ethyl ferulate, isopropyl ferulate, octyl ferulate, and oryzanyl ferulate;

[0297] certain oxidative stress defense enzymes, such as catalase, superoxide dismutase (SOD), lactoperoxidase, glutathione peroxidase and quinone reductases;

[0298] benzylcyclanones; substituted naphthalenones; pidolates (as described in particular in patent application EP 0 511 118); caffeic acid and its derivatives, gamma-oryzanol; melatonin, sulforaphane and extracts containing it (excluding watercress);

[0299] N,N'-bis(benzyl)ethylenediamine-N,N'-diacetic acid diisopropyl ester, as described in particular in patent applications WO 94 / 11338, FR 2 698 095, FR 2 737 205 or EP 0 755 925; And

[0300] deferoxamine (or desferal) as described in patent application FR 2 825 920.

[0301] The lipophilic antioxidant agents which are preferentially used are chalcones, more particularly phloretin or neohesperidin, diisopropyl ester of N,N'-bis(benzyl)ethylenediamine-N,N'-diacetic acid, or a maritime pine bark extract such as PYCNOGENOL®.

[0302] Examples of the lipophilic antioxidant agent include pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, nordihydroguaiaretic acid, propyl gallate, butylated hydroxyl toluene, butylated hydroxyl anisole, ascorbyl palmitate, tocopherol and mixtures thereof.

[0303] The lipophilic antioxidant agent may be at least one tocopherol selected from the group consisting of α-tocopherol, β-tocopherol, γ-tocopherol, δ-tocopherol and a mixture thereof. Vitamin E may also be used as a lipophilic antioxidant agent.

[0304] As (d) active skin care ingredient, anti-inflammatory or soothing agents may be mentioned.

[0305] As anti-inflammatory or soothing agents which may be used in the composition according to the present invention, mention may be made of: pentacyclic triterpenes and plant extracts (for example: Glycyrrhiza glabra) containing the latter, for example, [3-glyrrhetinic acid and its salts and / or its derivatives (glyceryrrhetinic acid monoglucuronide, stearyl glycyrrhetinate, 3-stearyloxyglycyrrhetic acid), ursolic acid and its salts, oleanolic acid and its salts, betulinic acid and its salts, bisabolol, an extract of Paeonia suffruticosa and / or lactiflora, phycosac-charides from the company Codif, an extract of Laminaria saccharina, canola oil, bisabolol and chamomile extracts, Allantoin, Sepivital EPC (phosphoric diester of vitamins E and C) from Seppic, unsaturated omega-3 oils such as rosehip oil, blackcurrant oil, ecchium oil, fish oil, plankton extracts,capryloyl glycine, Seppicalm VG (sodium palmitoylproline and Nymphaea alba) from Seppic, an extract of Pygeum, an extract of Boswellia serrata, an extract of Centipeda cunninghami, an extract of Helianthus annuus, an extract of Linum usitatissimum, tocotrienols, extracts of Cola nitida, Centella asiatica, piperonal, clove extract, Epilobium an-gustifolium extract, aloe vera, Bacopa monieri extract, phytosterols, nia-cinamide, cortisone, hydrocortisone, indomethacin and betamethasone. ,

[0306] Preferred anti-inflammatory agents for use in the present invention are Centella asiatica extracts, [3-glycyrrhetinic acid and its salts, α-bisabolol and niacinamide.

[0307] As (d) active skin care ingredient, mention may be made of hy- antioxidants drophiles such as ascorbic acid and its derivatives.

[0308] Ascorbic acid is generally in L-form, since it is usually extracted from natural products.

[0309] Due to its chemical structure (α-keto lactone) which makes it very sensitive to certain environmental parameters such as light, heat and aqueous media, it may be advantageous to use ascorbic acid in the form of a derivative or analogue chosen, for example, from ascorbic acid saccharide esters or phosphoryl ascorbic acid metal salts, alkali metal salts, esters and sugars.

[0310] The saccharide esters of ascorbic acid which can be used in the present invention are in particular the glycosyl, mannosyl, fructosyl, fucosyl, galactosyl, N-acetylucosamine and N-acetylmuramic derivatives of ascorbic acid, and a mixture thereof, and more particularly ascorbyl glucoside such as ascorbyl-2 glucoside, 2-OaD-glucopyranosyl L-ascorbic acid or 6-O-[3-D-galactopyranosyl L-ascorbic acid. These latter compounds and the processes for their preparation are described in particular in documents EP-A-0 487 404, EP-A-0 425 066 and JP 05 213 736.

[0311] As regards the metal salt of phosphoryl ascorbic acid, it may be chosen from alkali metals and in particular sodium, ascorbyl phosphates, alkaline earth metal ascorbyl phosphates and transition metal ascorbyl phosphates.

[0312] It is also possible to use ascorbic acid precursors such as active agent amides and active agent saccharide derivatives, which involve proteases or peptidases and glycosidases respectively as enzymes to release ascorbic acid in situ. These compounds are described in patent EP 0 667 145.

[0313] The active agent saccharide derivatives are especially selected from C3 to C6 saccharide derivatives. They are particularly selected from glucosyl, mannosyl, fructosyl, fucosyl, N-acetylglucosamine, galactosyl and N-acetylgalactosamine derivatives, N-acetylmuramic acid derivatives and sialic acid derivatives, and a mixture of these derivatives.

[0314] The second ascorbic acid precursors may be chosen from derivatives which are hydrolyzed by other enzymes, for example by esterases, phosphatases, sulfatases, etc. According to the present invention, the second active agent precursors may be chosen, for example, from phosphates, sulfates, palmitates, acetates, propionates; ferulates and, in general, alkyl or acyl esters, alkyl or acyl ethers of active agent. The acyl and alkyl radicals contain in particular from 1 to 30 carbon atoms. As an active skin care ingredient, mention may be made of acid 3-O-ethyl ascorbic.

[0315] In particular, the second precursor may be an ester derived from the reaction with a mineral acid such as a sulfate or a phosphate to react with a sulfatase or a phosphatase upon contact with the skin, and the second precursor may be an acyl or alkyl ester derived from the reaction with an organic acid, for example a palmitic acid, an acetic acid, a propionic acid, a nicotinic acid, a 1,2,3-propanetricarboxylic acid or a ferulic acid to react with a specific skin esterase.

[0316] Other derivatives are described, for example, in patent EP 1 430 883.

[0317] The analogues of ascorbic acid are more particularly its salts, in particular the alkali metal salts, for example sodium ascorbate, its esters, in particular its acetic, propionic or palmitic esters, in particular ascorbyl tetraisopalmitate, or its sugars, in particular glycosyl ascorbic acid.

[0318] As (d) active skin care ingredient, salicylic acid and its derivatives may be mentioned. Salicylic acid derivatives may be represented by formula (I) or its salt:

[0319] in which:

[0320] Ri represents hydrogen or a saturated, linear, branched or cyclized aliphatic hydrocarbon group or an alkoxy, ester or ketoxy group, or an unsaturated group having at least one conjugated or unconjugated double bond, where these groups may contain from 1 to 22 carbon atoms and may be substituted by at least one substituent selected from halogen atoms, trifluoromethyl groups and hydroxyl groups in a free form or esterified by an acid having from 1 to about 6 carbon atoms;

[0321] R2 represents a hydroxyl radical or an ester of formula (II): -oc-r4 (II)

[0322] where

[0323] R4 represents a saturated aliphatic hydrocarbon group or an alkenyl group having from 1 to 18 carbon atoms; and

[0324] R 3 represents hydrogen or a saturated or unsaturated aliphatic hydrocarbon group, linear or branched having from 2 to 30 carbon atoms, optionally containing one or more substituents such as those listed above.

[0325] As R3, alkyl and alkenyl radicals containing from 2 to 30 carbon atoms are suitable and are optionally substituted.

[0326] The preferred substituent is a hydroxyl radical.

[0327] When R3 is hydrogen, salts of the compounds of formula (I) may be used, in particular salts obtained by reaction with a base. Suitable bases include alkali metal hydroxides (sodium and potassium hydroxides), ammonium hydroxide, organic bases such as primary, secondary, tertiary or cyclic organic amines and amino acids. Specific examples of bases include glycine, taurine, alanine, valine, cysteine, trihydroxymethylaminomethane (TRISTA) and triethanolamine.

[0328] According to a preferred embodiment of the present invention, the compositions are prepared using derivatives of formula (I) where Ri contains at least 4 carbon atoms. For example, Ri may be a saturated linear alkyl or alkoxy radical having from 4 to 11 carbon atoms.

[0329] Derivatives of formula (I) wherein R2 is hydroxyl and R3 is hydrogen, include 5-n-octanoylsalicylic acid (CTFA name: Capryloyl Salicylic Acid), 5-n-decanoylsalicylic acid, 5-n-dodecanoylsalicylic acid, 5-n-octylsalicylic acid, 5-n-heptyloxysalicylic acid, 5-tert-octylsalicylic acid, 5-butoxysalicylic acid, 5-ethoxysalicylic acid, 5-methoxysalicylic acid, 5-propoxysalicylic acid, 5-methylsalicylic acid, 5-ethylsalicylic acid and 5-propylsalicylic acid, optionally treated with a base.

[0330] When R 1 represents hydrogen and R 2 a hydroxyl group, the derivative of formula (I) is a salicylic acid ester. Preferred compounds include esters of fatty alcohols such as dodecyl, hexadecyl, stearyl, cetyl, myristyl, linoleyl, octyl, oleyl and tridecyl alcohols, or esters of butyl, propyl and ethyl alcohols, or esters of polyols such as propylene glycol, butylene glycol, ethylene glycol or glycerol, or mixtures of these esters. Specific examples include cetyl salicylate, dodecyl salicylate and tridecyl salicylate.

[0331] It is even more preferable that the (d) skin care active ingredient is selected from the group consisting of 2-N-oleoylaminooctadecane-1,3-diol (2-oleamide-1,3-octadecanediol), tocopherol, retinol, stearyl glycyrrhetinate, ascorbic acid, ascorbyl tetraisopalmitate, 2-N-stearoylaminooctadecane-1,3,4-triol (ceramide NP), capryloyl salicylic acid and a mixture thereof.

[0332] The amount of the (d) active skin care ingredient(s) in the composition according to the present invention may be 0.001% by weight or more, preferably 0.003% by weight or more, and more preferably 0.005% by weight or more, relative to the total weight of the composition.

[0333] Furthermore, the amount of the (d) active skin care ingredient(s) in the composition according to the present invention may be 10% by weight or less, preferably 5% by weight or less, and more preferably 1% by weight or less, relative to the total weight of the composition.

[0334] Thus, the amount of the (d) active skin care ingredient(s) in the composition according to the present invention may range from 0.001% to 10% by weight, preferably from 0.003% to 5% by weight, more preferably from 0.005% to 1% by weight, relative to the total weight of the composition.

[0335] (Particle)

[0336] The (a) cationic polymer and the (b) anionic polymer, with or without the (c) fatty acid, may form at least one particle. Thus, the composition according to the present invention may include at least one particle. The (c) fatty acid may hydrophobize the particle.

[0337] The above particle may be a polyionic complex particle which may be formed by the (a) cationic polymer and the (b) anionic polymer. The (c) fatty acid may hydrophobize the polyionic complex particle.

[0338] The particle may optionally include the (d) skin care active ingredient. Thus, the (d) skin care active ingredient may be solubilized by the particle.

[0339] The size of the particle may be less than 1000 nm. Thus, the particle may be of nanometric size.

[0340] A particle size may be measured by a dynamic light scattering method. This particle size may be based on the volume average diameter.

[0341] The size of the particle in the composition according to the present invention may be less than 500 nm, preferably less than 400 nm, and more preferably less than 300 nm.

[0342] The particle size in the composition according to the present invention may be 10 nm or more, preferably 30 nm or more, and more preferably 50 nm or more.

[0343] The size of the particle may be from 10 nm to 500 nm, preferably from 30 nm to 400 nm, and more preferably from 50 nm to 300 nm.

[0344] ( Conditions )

[0345] According to the present invention, the following conditions (1) to (4) can be satisfied for the composition according to the present invention. 1. The total amount of the (a) cationic polymer, the (b) anionic polymer, the (c) fatty acid and the (d) skin care active ingredient is less than 1.5% by weight, preferably less than 1.0% by weight, and more preferably potentially less than 0.5% by weight, relative to the total weight of the composition; 2. The weight ratio of the amount of (a) cationic polymer / total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.7, preferably less than 0.5, and more preferably less than 0.3; 3. The weight ratio of the amount of (b) anionic polymer / total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.9, preferably less than 0.8, and more preferably less than 0.7; and 4. The weight ratio of the amount of (d) skin care active ingredient / total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.16, preferably less than 0.12 and more preferably less than 0.08.

[0346] It may be preferable that the composition according to the present invention also satisfies any one, preferably all, of the following conditions (5) to (8).

[0347] (5) The total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is greater than 0.01% by weight, preferably greater than 0.05% by weight, and more preferably greater than 0.1% by weight, relative to the total weight of the composition;

[0348] (6) The weight ratio between the amount of (a) cationic polymer / the total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is greater than 0.01, preferably greater than 0.05 and more preferably greater than 0.1;

[0349] (7) The weight ratio between the amount of the anionic polymer (b) / the total amount of the (a) cationic polymer, the (b) anionic polymer, the (c) fatty acid and the (d) skin care active ingredient is greater than 0.3, preferably greater than 0.4 and more preferably greater than 0.5; and

[0350] (8) The weight ratio between the amount of the (d) skin care active ingredient / the total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is greater than 0.005, preferably greater than 0.01, and more preferably greater than 0.05.

[0351] (Water)

[0352] The composition according to the present invention may comprise (e) water.

[0353] The amount of (e) water may be 50% by weight or more, preferably 55% by weight or more, and more preferably 60% by weight or more, relative to the total weight of the composition.

[0354] Furthermore, the amount of (e) water may be 99% by weight or less, preferably 98% by weight or less, and more preferably 97% by weight or less, relative to the total weight of the composition.

[0355] The amount of (e) water may be from 50% to 99% by weight, preferably from 55% to 98% by weight, and more preferably from 60% to 97% by weight, relative to the total weight of the composition.

[0356] (pH)

[0357] The pH of the composition according to the present invention may be from 3 to 9, preferably from 3.3 to 8.5 and, more preferably, from 3.5 to 8.

[0358] At pH 3 to 9, the above particle which may be a polyionic complex particle which may be formed by the (a) cationic polymer and the (b) anionic polymer, wherein the (c) fatty acid may hydrophobize the polyionic complex particle, may be very stable.

[0359] The pH of the composition according to the present invention may be corrected by the addition of at least one alkaline agent and / or at least one acid. The pH of the composition according to the present invention may also be corrected by the addition of at least one buffering agent.

[0360] (Alkaline agent)

[0361] The composition according to the present invention may comprise at least one alkaline agent. Two or more alkaline agents may be used in combination. Thus, a single type of alkaline agent or a combination of different types of alkaline agents may be used.

[0362] The alkaline agent may be an inorganic alkaline agent. It is preferable that the inorganic alkaline agent is selected from the group consisting of ammonia, alkali metal hydroxides, alkaline earth metal hydroxides, alkali metal phosphates and monohydrogen phosphates such as sodium phosphate or sodium monohydrogen phosphate.

[0363] Examples of inorganic alkali metal hydroxides include sodium hydroxide and potassium hydroxide. Examples of alkaline earth metal hydroxides include calcium hydroxide and magnesium hydroxide. As the inorganic alkali agent, sodium hydroxide is preferable.

[0364] The alkaline agent may be an organic alkaline agent. It is preferable that the organic alkaline agent is selected from the group consisting of monoamines and their derivatives; diamines and their derivatives; polyamines and their derivatives; basic amino acids and their derivatives; oligomers of basic amino acids and their derivatives; polymers of basic amino acids and their derivatives; urea and its derivatives; and guanidine and its derivatives.

[0365] Examples of organic alkaline agents include alkanolamines such as mono-, di- and triethanolamine, and isopropanolamine; urea, guanidine and their derivatives; basic amino acids such as lysine, ornithine or arginine and diamines such as those described in the structure below: R1 R3 NRN R2 Z X R4

[0366] wherein R denotes an alkylene such as propylene optionally substituted by a hydroxyl or a C1-C4 alkyl radical, and Rh R2, R3 and R4 independently denote a hydrogen atom, an alkyl radical or a C1-C4 hydroxyalkyl radical, an example of which may be 1,3-propanediamine and its derivatives.

[0367] The alkaline agent(s) may be used in an amount ranging from 0.001% to 15% by weight, preferably from 0.002% to 10% by weight, and more preferably from 0.003% to 5% by weight, relative to the total weight of the composition, depending on their solubility.

[0368] (Acid)

[0369] The composition according to the present invention may comprise at least one acid. Two or more acids may be used in combination. Thus, a single type of acid or a combination of different types of acids may be used.

[0370] As the acid, any inorganic or organic acids, preferably inorganic, which are commonly used in cosmetic products may be mentioned. A monovalent acid and / or a polyvalent acid may be used. A monovalent acid such as citric acid, lactic acid, sulfuric acid, phosphoric acid and hydrochloric acid (HCl) may be used. Lactic acid may be preferable.

[0371] The acid(s) may be used in an amount ranging from 0.001% to 15% by weight, preferably from 0.002% to 10% by weight, more preferably from 0.003% to 5% by weight, relative to the total weight of the composition, depending on their solubility.

[0372] (Optional ingredient)

[0373] The composition according to the present invention may comprise, in addition to the above-mentioned ingredients, one or more optional ingredients typically employed in cosmetics, specifically, oils; UV filters; surfactants / emulsifiers; hydrophilic or lipophilic thickeners, derived, for example, from synthetic polymers other than the (a) cationic polymer or the (b) anionic polymer; volatile or non-volatile organic solvents; amphoteric polymers; non-ionic polymers such as beta-glucan; silicones and silicone derivatives; natural extracts derived from animals or plants other than the (a) cationic polymer or the (b) anionic polymer; waxes; and the like, in a range which does not alter the effects of the present invention.

[0374] The composition according to the present invention may comprise the above optional ingredient(s) in an amount of 0.01% to 30% by weight, preferably 0.05% to 20% by weight, and more preferably 0.1% to 10% by weight, relative to the total weight of the composition.

[0375] The composition according to the present invention does not comprise a surfactant having at least one polyoxyethylene unit or at least one surfactant having at least one polyoxyethylene unit in an amount of 1% by weight or less, preferably 0.1% by weight or less, and more preferably 0.01% by weight or less, relative to the total weight of the composition. It is particularly preferable that the composition according to the present invention does not include a surfactant / emulsifier having at least one polyoxyethylene unit.

[0376] The composition according to the present invention may include a very limited quantity of synthetic thickener(s) and / or organic solvent(s) in order to respect the environment.

[0377] The amount of the synthetic thickener(s) or organic solvent(s) in the composition according to the present invention may be 1% by weight or less, preferably 0.1% by weight or less, and more preferably 0.01% by weight or less, relative to the total weight of the composition. It is particularly preferable that the composition according to the present invention does not include either a synthetic thickener or an organic solvent. [Preparation]

[0378] The composition according to the present invention can be prepared by mixing the essential ingredient(s) as explained above, and the optional ingredient(s), if necessary, as explained above.

[0379] The method and means for mixing the above essential and optional ingredients are not limited. Any conventional method and means can be used for mixing the above essential and optional ingredients to prepare the composition according to the present invention.

[0380] The composition according to the present invention can be prepared by simple or easy mixing with a conventional mixing means such as a stirrer and a homogenizer. In addition, heating may not be necessary. Therefore, the process of preparing the composition according to the present invention can be environmentally friendly. [Cosmetic application]

[0381] The composition according to the present invention may be intended to be used as a cosmetic composition. Thus, the cosmetic composition according to the present The invention may be intended to be applied to a keratinous substance. The keratinous substance herein refers to a material containing keratin as a main constituent element and, examples thereof include skin, scalp, lips, hair or body hair and the like. Thus, it is preferable that the cosmetic composition according to the present invention is used for a cosmetic process for the keratinous substance, in particular the skin.

[0382] Thus, the cosmetic composition according to the present invention may be a cosmetic composition for the skin, preferably a cosmetic skin care composition or a skin makeup composition, and more preferably a cosmetic skin care composition. [Shape]

[0383] The composition according to the present invention may be present in any form.

[0384] For example, if the composition according to the present invention includes oil, the oil may form fatty phases, (e) water may form an aqueous phase, and the fatty phases may be dispersed in the aqueous phase. Thus, the aqueous phase may function as a continuous phase, and the fatty phase may function as a dispersed phase. In other words, the composition according to the present invention may be in the form of an O / W dispersion such as an O / W emulsion. If the composition according to the present invention is of the O / W type, it may provide a sensation of freshness due to (e) the water which forms the external phase thereof.

[0385] The composition according to the present invention may have a transparent or translucent appearance, preferably a transparent appearance.

[0386] Transparency may be measured by turbidity measurement (e.g., with the HACH 2100Q portable turbidimeter). The turbidity of the composition according to the present invention may be less than 400 NTU (translucent), preferably less than 350 NTU, more preferably less than 300 NTU (transparent). [ Movie ]

[0387] The composition according to the present invention can be used to easily prepare a film.

[0388] If ingredients (a) and (b), with or without ingredient (c), form particles, the particles may aggregate and integrate into a continuous film.

[0389] Thus, the present invention may also relate to a process for preparing a film, preferably a cosmetic film, optionally with a thickness of 0.5 µm or more, more preferably 1.0 µm or more, and even more preferably 1.5 µm or more, comprising:

[0390] the application on a substrate, preferably a keratinous substance, more pre- preferably the skin, of the composition according to the present invention; and

[0391] drying the composition.

[0392] The upper limit of the thickness of the film according to the present invention is not limited. Thus, for example, the thickness of the film according to the present invention may be 1 mm or less, preferably 500 μm or less, more preferably 300 μm or less, and even more preferably 100 μm or less.

[0393] Since the process for preparing a film according to the present invention comprises the steps of applying the composition according to the present invention to a substrate, preferably a keratinous substance, and more preferably the skin, and drying the composition, the process according to the present invention does not require spin coating or spraying, and therefore it is possible to easily prepare a relatively thick film. Thus, the process for preparing a film according to the present invention can prepare a relatively thick film without any special equipment such as spin coatings and spraying machines.

[0394] Even though the film according to the present invention is relatively thick, it remains thin and may be transparent, and therefore may not be easy to perceive. Thus, the film according to the present invention can be preferentially used as a cosmetic film.

[0395] If the substrate is not a keratinous substance such as skin, the composition according to the present invention may be applied to a substrate made of any material other than keratin. The materials of the non-keratinous substrate are not limited. Two or more materials may be used in combination. Thus, a single type of material or a combination of different types of materials may be used. In any case, it is preferable that the substrate be soft or elastic.

[0396] If the substrate is not a keratinous substance, it is preferable that the substrate be water-soluble, since it is possible to leave the film according to the present invention by washing the substrate with water. Examples of water-soluble materials include poly(methacrylic) acids, polyethylene glycols, polyacrylamides, polyvinyl alcohol (PVA), starch, cellulose acetates, and the like. PVA is preferable.

[0397] If the non-keratinous substrate is in the form of a sheet, it may have a thickness greater than that of the film according to the present invention, in order to facilitate handling of the film attached to the substrate sheet. The thickness of the non-keratinous substrate sheet is not limited, but may be from 1 μm to 5 mm, preferably from 10 μm to 1 mm, and more preferably from 50 to 500 μm.

[0398] It is more preferable that the film according to the present invention can be released from the non-keratinous substrate. The release mode is not limited. Therefore, the film according to the present invention can be peeled off from the non-keratinous substrate, or released by dissolving the substrate sheet in a solvent such as water.

[0399] The present invention may also relate to:

[0400] (1) A film, preferably a cosmetic film, optionally of a thickness preferably greater than 0.5 qm, more preferably 1.0 qm or more, and even more preferably 1.5 qm or more, prepared by a process comprising:

[0401] the application to a substrate, preferably a keratinous substance, and more preferably the skin, of the composition according to the present invention; and

[0402] drying the composition,

[0403] and

[0404] (2) A film, preferably a cosmetic film, optionally of a thickness preferably greater than 0.5 qm, more preferably 1.0 qm or more, even more preferably 1.5 pm or more, comprising:

[0405] (a) at least one cationic polymer;

[0406] (b) at least one anionic polymer;

[0407] (c) at least one fatty acid; and

[0408] (d) at least one skin care active ingredient,

[0409] in which

[0410] the weight ratio between the amount of (a) cationic polymer / total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.7, preferably less than 0.5, and more preferably less than 0.3,

[0411] the weight ratio of the amount of (b) anionic polymer / total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.9, preferably less than 0.8, and more preferably less than 0.7, and

[0412] the weight ratio of the amount of (d) skin care active ingredient to the total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid, and (d) skin care active ingredient is less than 0.16, preferably less than 0.12, and more preferably less than 0.08.

[0413] The above explanations regarding the (a) cationic polymer, the (b) anionic polymers, the (c) fatty acid, and the (d) skin care active ingredient can be applied to those of films (1) and (2) above.

[0414] The film thus obtained may be self-supporting. The term "self-supporting" herein means that the film may be in the form of a sheet and may be handled as an independent sheet without the assistance of a substrate or support. Thus, the term "self-supporting" may have the same meaning as "self-supporting".

[0415] It is preferable that the film according to the present invention is hydrophobic.

[0416] In this specification, the term "hydrophobic" means that the solubility of the film in water (preferably with a volume of 1 liter) at 20 to 40 °C, prefer preferably from 25 to 40°C, and more preferably from 30 to 40°C is less than 10% by weight, preferably less than 5% by weight, more preferably less than 1% by weight, and even more preferably less than 0.1% by weight, relative to the total weight of the film. It is very preferable that the film is not soluble in water.

[0417] If the film according to the present invention is hydrophobic, the film can have water-resistant properties and, therefore, it can remain on a keratinous substance such as skin, even if the surface of the keratinous substance is wet due to, for example, perspiration or rain. Thus, when the film according to the present invention provides a cosmetic effect, the cosmetic effect can last for a long time.

[0418] On the other hand, the film according to the present invention can be easily removed from a keratinous substance such as skin under alkaline conditions such as a pH of 8 to 12, preferably 9 to 11. Therefore, the film according to the present invention is difficult to remove with water, while it can be easily removed with a soap which can provide such alkaline conditions.

[0419] The film according to the present invention may comprise at least one layer of biocompatible and / or biodegradable polymer. Two or more biocompatible and / or biodegradable polymers may be used in combination. Thus, a single type of biocompatible and / or biodegradable polymer or a combination of different types of biocompatible and / or biodegradable polymers may be used.

[0420] The term "biocompatible" polymer in this specification means that the polymer does not have excessive interaction between the polymer and cells of the living body including the skin, and that the polymer is not recognized by the living body as a foreign material.

[0421] The term "biodegradable" polymer in this specification means that the polymer can be degraded or broken down in a living body due to, for example, the metabolism of the living body itself or the metabolism of microorganisms that may be present in the living body. In addition, the biodegradable polymer can be degraded by hydrolysis.

[0422] If the film according to the present invention includes a biocompatible and / or biodegradable polymer, it is less irritable or non-irritable to the skin and / or it may not contaminate environments.

[0423] In fact, the film according to the present invention may include (a) at least one cationic polymer which may be chosen from chitosans, and / or (b) at least one anionic polymer which may be chosen from polysaccharides, such as carrageenan, which are biodegradable polymers.

[0424] In addition, due to the use of a biocompatible and / or biodegradable polymer, the cosmetic sheet according to the present invention can adhere well to the skin.

[0425] The film according to the present invention can be used for cosmetic treatments of keratinous substances, preferably the skin, in particular the face. The film according to the present invention can be in any form. For example, it can be used as a mask sheet for the entire face or as a patch for a part of the face such as the cheek, nose and eye contour. [Cosmetic process and use]

[0426] The present invention also relates to:

[0427] a cosmetic process for a keratinous substance such as skin, comprising: applying to the keratinous substance the composition according to the present invention; and drying the composition to form a cosmetic film on the keratinous substance; or

[0428] a use of the composition according to the present invention for the preparation of a cosmetic film on a keratinous substance such as the skin.

[0429] The cosmetic process here designates a non-therapeutic cosmetic process of care and / or makeup of the surface of a keratinous substance such as the skin.

[0430] In both the above process and use, the above cosmetic film is resistant to water of a pH of 7 or less, and can be removed with water of a pH greater than 7, preferably 8 or more, and more preferably 9 or more.

[0431] In other words, the above cosmetic film can be water-resistant under neutral or acidic conditions such as a pH of 7 or less, preferably in a range of 6 or more and 7 or less and more preferably in a range of 5 or more and 7 or less, while the above cosmetic film can be removed under alkaline conditions such as a pH of more than 7, preferably 8 or more, and more preferably 9 or more. The upper limit of the pH is preferably 13, more preferably 12, and even more preferably 11.

[0432] Accordingly, the above cosmetic film can be water-resistant and thus can remain on a keratinous substance such as skin even if the surface of the keratinous substance is wet due to, for example, perspiration and rain. On the other hand, the above cosmetic film can be easily removed from a keratinous substance such as skin under alkaline conditions. Therefore, the film according to the present invention is difficult to remove with water, while it can be easily removed with a soap which can provide alkaline conditions.

[0433] Furthermore, the above cosmetic film may have cosmetic effects such as capturing sebum, mattifying the appearance of a keratinous substance such as skin, absorbing or absorbing a bad odor, and / or protecting the keratinous substance from, for example, dirt or pollutants, due to the properties of the complex in the cosmetic film, even if the cosmetic film does not include any anti-sebum, deodorant, or protectant agent.

[0434] In addition, the above cosmetic film can immediately change or modify the appearance of the skin by changing the reflection of light on the skin and the like, even if the cosmetic film does not include any cosmetic active ingredient. Therefore, it may be possible for the above cosmetic film to conceal skin defects such as pores or wrinkles. Furthermore, the above cosmetic film can immediately change or modify the touch feeling of the skin by changing the surface roughness of the skin and the like. Furthermore, the above cosmetic film can immediately protect the skin by covering the surface of the skin and protecting the skin, as a barrier, against environmental aggressions such as pollutants, contaminants and the like.

[0435] The above cosmetic effects can be adjusted or regulated by changing the chemical composition, thickness and / or surface roughness of the above cosmetic film.

[0436] Since the above cosmetic film includes (d) at least one skin care active ingredient, the cosmetic film may have cosmetic effects provided by the (d) skin care active ingredient(s). For example, if the cosmetic film includes at least one skin care active ingredient selected from anti-aging agents, such as antioxidants, the cosmetic film may treat skin aging.

[0437] It is also possible to apply a cosmetic makeup composition to the cosmetic film or sheet according to the present invention after its application to the skin.

[0438] The present invention may also relate to a use of: a. at least one cationic polymer; b. at least one anionic polymer and c. at least one fatty acid, in a composition comprising: d. at least one active skin care ingredient; and e. water,

[0439] in which

[0440] the total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 1.5% by weight, preferably less than 1.0% by weight, and more preferably less than 0.5% by weight, relative to the total weight of the composition,

[0441] the weight ratio between the amount of (a) cationic polymer / total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.7, preferably less than 0.5, and more preferably less than 0.3,

[0442] the weight ratio of the amount of (b) anionic polymer / total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.9, preferably less than 0.8, and more preferably less than 0.7, and

[0443] the weight ratio between the amount of (d) skin care active ingredient and the total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.16, preferably less than 0.12 and more preferably less than 0.08,

[0444] in order to solubilize the (d) active skin care ingredient in the composition.

[0445] The present invention may also relate to a use of: a. at least one cationic polymer; b. at least one anionic polymer and c. at least one fatty acid, in a composition comprising: d. at least one active skin care ingredient; and e. water,

[0446] in which

[0447] the total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 1.5% by weight, preferably less than 1.0% by weight, and more preferably less than 0.5% by weight, relative to the total weight of the composition,

[0448] the weight ratio between the amount of (a) cationic polymer / total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.7, preferably less than 0.5, and more preferably less than 0.3,

[0449] the weight ratio of the amount of (b) anionic polymer / total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.9, preferably less than 0.8, and more preferably less than 0.7, and

[0450] the weight ratio between the amount of (d) skin care active ingredient and the total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.16, preferably less than 0.12 and more preferably less than 0.08,

[0451] in order to make the composition transparent or translucent.

[0452] The present invention may also relate to a use of: a. at least one cationic polymer; b. at least one anionic polymer and c. at least one fatty acid, in a composition comprising: d. at least one active skin care ingredient; and e. water,

[0453] in which

[0454] the total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 1.5% by weight, preferably less than 1.0% by weight, and more preferably less than 0.5% by weight, relative to the total weight of the composition,

[0455] the weight ratio between the amount of (a) cationic polymer / total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.7, preferably less than 0.5, and more preferably less than 0.3,

[0456] the weight ratio between the amount of (b) anionic polymer / total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.9, preferably less than 0.8, and more preferably less than 0.7, and

[0457] the weight ratio between the amount of (d) skin care active ingredient and the total amount of (a) cationic polymer, (b) anionic polymer, (c) fatty acid and (d) skin care active ingredient is less than 0.16, preferably less than 0.12 and more preferably less than 0.08,

[0458] in order to improve the skin penetration of the (d) active skin care ingredient.

[0459] The above explanations regarding the (a) cationic polymer, the (b) anionic polymers, the (c) fatty acid, the (d) skin care active ingredient and (e) water may apply to those of the above uses. EXAMPLES

[0460] The present invention will be described in more detail with the aid of examples. However, these examples should not be construed as limiting the scope of the present invention. [Example 1 and Comparative Examples 1 to 3] [Preparations]

[0461] Each of the compositions according to Example 1 and Comparative Examples 1 to 3 was prepared by mixing the ingredients shown in Table 1. The numerical values ​​of the amounts of the ingredients in Table 1 are all based on a "% by weight" of raw materials.

[0462] [Tables 1] Ex. 1 Ex. Comp. 1 Ex. Comp. 2 Ex. Comp. 3 Caprylyl Glycol 0.3 0.3 0.3 0.3 Chitosan (a) 0.027 0.027 0.027 - Water qs 100 qs 100 qs 100 qs 100 Carrageenan (b) 0.1 0.1 - 0.3 Glycerin 3 3 3 3 Oleic acid (c) 0.018 - 0.018 0.054 2-oleamide-l,3-octadecanediol (d) 0.01 0.01 0.01 0.03 Pentylene glycol 1 1 1 1 Lactic acid qs. pH 5 qs. pH 5 qs. pH 5 qs. pH 5 (a)+(b)+(c)+(d) 0.155 0.137 0.055 0.384 (b) / [(a)+(b)+(c)+(d)] xlOO 64.5 73.0 - 78.1 (a) / [(a)+(b)+(c)+(d)] xlOO 17.4 19.7 49.1 - (c) / [(a)+(b)+(c)+(d)] xlOO 11.6 - 32.7 14.1 (d) / [(a)+(b)+(c)+(d)] xlOO 6.5 7.3 18.2 7.8 Appearance Good Good Good Poor Solubility Good Poor Good Poor Particle size (nm) 92 NA >1000 >1000 Turbidity (NTU) 110 50 500 NA

[0463] nd: not available [Evaluations]

[0464] (Aspect)

[0465] The appearance of each of the compositions according to Example 1 and the Comparative Examples 1 to 3 was visually observed. The results of visual observation were classified as follows.

[0466] Good: the appearance was transparent or translucent

[0467] Precipitate: the appearance was translucent but precipitation was observed

[0468] Bad: the appearance was cloudy

[0469] The results are shown in Table 1.

[0470] The compositions according to Example 1 and Comparative Examples 1 and 2 were transparent or translucent.

[0471] The composition according to Comparative Example 3 was cloudy.

[0472] (Solubility)

[0473] The solubility of ceramide (2-oleamide-1,3-octadecanediol) in each of the compositions according to Example 1 and Comparative Examples 1 to 3 was visually observed. The results of the visual observation were classified as follows.

[0474] Good: the ceramide has been solubilized

[0475] Bad: Ceramide has not been solubilized

[0476] The results are shown in Table 1.

[0477] Ceramide was solubilized in the composition according to Example 1 and Comparative Example 2, while ceramide was not solubilized in the compositions according to Comparative Examples 1 and 3.

[0478] (Particle size)

[0479] A particle size analyzer (Dynamic Light Scattering, ELSZ2000, Otsuka) was used to determine the particle size in the compositions according to Example 1 and Comparative Examples 1 to 3 at room temperature (25°C).

[0480] The results are shown in Table 1.

[0481] The particle size of the particles in the composition according to Example 1 was small such that it was nanometric in size.

[0482] The particle size of the particles in the composition according to Comparative Examples 2 and 3 was not small.

[0483] It was not possible to measure the particle size for the compositions according to Comparative Example 1.

[0484] (Turbidity)

[0485] The turbidity of each of the compositions according to Example 1 and Comparative Examples 1 to 3 was measured at room temperature (25°C) using a turbidimeter (2100Q portable, HACH company).

[0486] The results are shown in Table 1 as "NTU". The lower the NTU value, the more transparent the composition.

[0487] The turbidity of the compositions according to Comparative Example 3 was too high. Examples 2 to 12 [Preparations]

[0488] Each of the compositions according to Examples 2 to 12 was prepared by mixing the ingredients shown in Tables 2 and 3. The numerical values ​​of the amounts of the ingredients shown in Tables 2 and 3 are all based on "% by weight" of raw materials. Ex. 2 Ex. 3 Ex. 4 Ex. 5 Caprylyl Glycol 0.3 0.3 0.3 0.3 Chitosan (a) 0.027 0.027 0.027 0.027 Water qsp 100 qsp 100 qsp 100 qsp 100 Carrageenan (b) 0.1 0.1 0.1 0.1 Glycerin 3 3 3 3 Stearic acid (c) 0.018 - - - Isostearic acid (c) - 0.018 - - Behenic acid (c) - - 0.018 - Decanoic acid (c) - - - 0.018 2-oleamide-l,3-octadecanediol (d) 0.01 0.01 0.01 0.01 Pentylene glycol 1 1 1 1 Lactic acid qs. pH 5 qs. pH 5 qs. pH 5 qs. pH 5 (a)+(b)+(c)+(d) 0.155 0.155 0.155 0.155 (b) / [(a)+(b)+(c)+(d)] xlOO 64.5 64.5 64.5 64.5 (a) / [(a)+(b)+(c)+(d)] xlOO 17.4 17.4 17.4 17.4 (c) / [(a)+(b)+(c)+(d)] xlOO 11.6 11.6 11.6 11.6 (d) / [(a)+(b)+(c)+(d)] xlOO 6.5 6.5 6.5 6.5 Appearance Good Good Good Good Solubility Good Good Good Good Particle size (nm) 478 75.7 292 135.2 Turbidity (NTU) 104 39.2 193 81 Ex. 6 Ex. 7 Ex. 8 Ex. 9 Ex. 10 Ex. 11 Ex. 12 Caprylyl Glycol 0.3 0.3 0.3 0.3 0.3 0.3 0.3 Chitosan (a) 0.027 0.027 0.027 0.027 0.027 0.027 0.027 Water qs 100 qs 100 qs 100 qs 100 qs 100 qs 100 qs 100 Carrageenan (b) 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Glycerin 3 3 3 3 3 3 3 Oleic acid (c) 0.018 0.018 0.018 0.018 0.018 0.018 0.018 Tocopherol (d) 0.01 - - - - - - Retinol - 0.01 - - - - - Stearyl Glycyrrhetinate - - 0.01 - - - - Ascorbic Acid - - - 0.01 - - - Ascorbyl Tetraisopalmitate - - - - 0.01 - - Ceramide NP - - - - - 0.01 - Capryloyl salicylic acid - - - - - - 0.01 Pentylene Glycol 1 1 1 1 1 1 1 Lactic Acid qs. pH 5 qs. pH 5 qs. pH 5 qs. pH 5 qs. pH 5 qs.pH 5 (a)+(b)+(c)+(d) 0.155 0.155 0.155 0.155 0.155 0.155 0.155 (b) / [(a)+(b)+(c)+(d)] xlOO 64.5 64.5 64.5 64.5 64.5 64.5 64.5 (a) / [(a)+(b)+(c)+(d)] 11.6 (d) / [(a)+(b)+(c)+(d)] xlOO 6.5 6.5 6.5 6.5 6.5 6.5 6.5 Appearance Good Good Good Good Good Good Good . Solubility Good Good Good Good Good Good Particle size (nm) 71.5 201.7 111.2 112.8 261.6 131.9 135.4 Turbidity (NTU) 28.3 192 62.2 33.6 265 43.3 20.7 [Evaluations]

[0491] (Aspect)

[0492] The appearance of each of the compositions according to Examples 2 to 12 was visually observed. The results of the visual observation were classified as follows.

[0493] Good: the appearance was transparent or translucent

[0494] Precipitate: the appearance was translucent but precipitation was observed

[0495] Bad: the appearance was cloudy

[0496] The results are shown in Tables 2 and 3.

[0497] The compositions according to Examples 2 to 12 were stable.

[0498] (Solubility)

[0499] The solubility of ceramide (2-oleamide-1,3-octadecanediol) in each of the compositions according to Examples 2 to 5 was visually observed. In addition, the solubility of each of the various cosmetic active ingredients (d) in each of the compositions according to Examples 6 to 12 was visually observed. The results of the visual observation were classified as follows.

[0500] Good: the ceramide or cosmetic active ingredient has been solubilized

[0501] Bad: the ceramide or cosmetic active ingredient has not been solubilized

[0502] The results are shown in Tables 2 and 3.

[0503] The ceramide or the cosmetic active ingredient has been solubilized in the composition according to Examples 2 to 12.

[0504] (Particle size)

[0505] A particle size analyzer (Dynamic Light Scattering, ELSZ2000, Otsuka) was used to determine the particle size in the compositions according to Examples 2 to 12 at room temperature (25°C).

[0506] The results are shown in Tables 2 and 3.

[0507] The particle size of the particles in the composition according to Examples 2 to 12 was small such that it was nanometer in size.

[0508] (Turbidity)

[0509] The turbidity of each of the compositions according to Examples 2 to 12 was measured at room temperature (25°C) using a turbidimeter (2100Q portable, Hach Company).

[0510] The results are shown in Tables 2 and 3 as "NTU". The lower the NTU value, the more transparent the composition.

[0511] In addition, the compositions according to the present invention include one or more environmentally friendly ingredients.

Claims

Claims

1. Composition, preferably cosmetic composition, more preferably cosmetic composition for a keratinous substance, and more preferably cosmetic composition for the skin, comprising: (a) at least one cationic polymer; (b) at least one anionic polymer and (c) at least one fatty acid.

2. The composition of claim 1, wherein the composition further comprises (d) at least one skin care active ingredient, preferably with a logP of -1 or greater, more preferably 1 or greater, and even more preferably 2 or greater.

3. A composition according to claim 1 or 2, wherein the total amount of the (a) cationic polymer, the (b) anionic polymer, the (c) fatty acid and the (d) skin care active ingredient is less than 1.5% by weight, preferably less than 1.0% by weight, and more preferably less than 0.5% by weight, relative to the total weight of the composition, the weight ratio of the amount of the (a) cationic polymer / the total amount of the (a) cationic polymer, the (b) anionic polymer, the (c) fatty acid and the (d) skin care active ingredient is less than 0.7, preferably less than 0.5, and more preferably less than 0.3, the weight ratio of the amount of the (b) anionic polymer / the total amount of the (a) cationic polymer, the (b) anionic polymer, the (c) fatty acid and the (d) skin care active ingredient is less than 0.7, preferably less than 0.5, and more preferably less than 0.3, the skin is less than 0.9, preferably less than 0.8, and more preferably less than 0,7, and the weight ratio of the amount of the (d) skin care active ingredient / the total amount of the (a) cationic polymer, the (b) anionic polymer, the (c) fatty acid and the (d) skin care active ingredient is less than 0.16, preferably less than 0.12, and more preferably less than 0.08.,

4. A composition according to any one of claims 1 to 3, wherein the (a) cationic polymer is hydrophobized by the (c) fatty acid.

5. Composition according to any one of claims 1 to 4, in wherein the (a) cationic polymer is selected from the group consisting of alkyldiallylamine cyclopolymers and dialkyldiallylammonium cyclopolymers such as (co)polydiallyldialkyl ammonium chloride, (co)polyamines such as (co)polylysines and chitosans, cationic (co)polyamino acids such as collagen, cationic cellulose polymers and salts thereof.

6. Composition according to any one of claims 1 to 5, in which the (a) cationic polymer has a molecular weight of less than 20,000, preferably less than 15,000 and more preferably less than 10,000.

7. A composition according to any one of claims 1 to 6, wherein the (b) anionic polymer is selected from the group consisting of polysaccharides such as carrageenan, alginic acid, hyaluronic acid and cellulose polymers, anionic (co)polyamino acids such as (co)polyglutamic acids, (co)poly(meth)acrylic acids, (co)polyamic acids, (co)polystyrene sulfonate, (co)poly(vinyl sulfates), dextran sulfate, chondroitin sulfate, (co)polymaleic acids, polyfumaric acids, (co)polymers of maleic acids and their salts.

8. Composition according to any one of claims 1 to 7, in which the (c) fatty acid is chosen from saturated and unsaturated fatty acids, linear or branched in C4-C26, preferably C6-C24, more preferably C8-C22.

9. Composition according to any one of claims 1 to 8, wherein the composition comprises at least one particle with a particle size of less than 1000 nm, preferably less than 500 nm, and more preferably less than 300 nm.

10. A cosmetic process for a keratinous substance such as skin, comprising applying to the keratinous substance the composition according to any one of claims 1 to 9; and drying the composition to form a cosmetic film on the keratinous substance.

Citation Information

Patent Citations

  • pseudoceramides, processes for their production and their use

    DE4402929C1

  • New pseudo-ceramide cpds.

    DE4420736C1

  • pseudoceramides

    DE4424530A1

  • oligohydroxydicarboxylic acid derivatives

    DE4424533A1

  • Polyquaternary ammonium compounds and cosmetic compositions containing them

    EP0122324A1